Document:

EX-10.4

 Exhibit 10.4 

Execution Version 
 THE WARRANTS AND
THE SECURITIES ISSUABLE UPON EXERCISE OF THE WARRANTS HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE,
SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (A) A REGISTRATION STATEMENT UNDER THE ACT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR (B) THE
TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE COMPANY REQUESTS, AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, TO SUCH EFFECT
HAS BEEN RENDERED. 
 SUBSCRIPTION AND REGISTRATION RIGHTS AGREEMENT 

THIS SUBSCRIPTION AND REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of September 2, 2022, is made
and entered into by and among Tritium DCFC Limited (ACN 650 026 314), an Australian public company (the “Company”), and the undersigned parties listed under Holder on the signature pages hereto (each such party, together with
any person or entity who hereafter becomes a party to this Agreement pursuant to Section 1.1 or 5.2 of this Agreement, a “Holder” and collectively, the “Holders”).
Capitalized terms used in this Agreement and not otherwise defined elsewhere in this Agreement shall have the meanings set forth in Section 7.1 hereof, and capitalized terms used but not otherwise defined in this Agreement shall have the
meanings given in the Warrant Agreement (as defined below). 
 RECITALS 

WHEREAS, in connection with the financing transactions described under the Senior Loan Note Subscription Agreement, dated as of
September 2, 2022 (the “LNSA”), among the Company and the lenders party thereto, the Company is issuing to the Holders pursuant to this Agreement and the Warrant Agreement, dated as of September 2, 2022 (the
“Warrant Agreement”), among the Company, Computershare Inc., a Delaware corporation (“Computershare”), and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company
(together with Computershare, collectively, the “Warrant Agent”), warrants to subscribe for and purchase ordinary shares of the Company (“Ordinary Shares”) (such warrants being referred to as
“Warrants”); 
 WHEREAS, in connection with the Financial Close and the Accordion Facility Effective Date (as
defined in the LNSA), if any, the Holders desire to enter into this Agreement, pursuant to which the Company shall (i) grant and issue the Warrants to the Holders and (ii) grant the Holders certain registration rights with respect to
certain securities of the Company, as set forth in this Agreement; and 
 WHEREAS, after (i) the Financial Close, the Initial
Holders (as defined below) will own Warrants to subscribe for and purchase an aggregate of 2,030,840 Ordinary Shares, subject to adjustment as contemplated herein and (ii) the Accordion Facility Effective Date, if any, the Accordion Holders (as
defined below) will own Warrants to subscribe for and purchase an aggregate of up to 135,389 Ordinary Shares, subject to adjustment as contemplated herein (the number of Ordinary Shares subject to Warrants, as adjusted, the “Warrant
Shares”). 
 NOW, THEREFORE, in consideration of the representations, covenants and agreements contained herein,
and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows: 

 ARTICLE I 

WARRANTS 
 1.1 Grant of
Warrant. (a) Subject to the conditions set forth in this Agreement, in connection with the transactions contemplated by the LNSA, the Company hereby grants and issues to each Holder on the date hereof and on the Accordion Facility Effective
Date the number of Warrants evidencing the right to subscribe for and purchase, in each case, in accordance with the terms and conditions set forth herein and in the Warrant Agreement, the Warrant Shares. For each Holder that is a Facility A Lender
(as defined in the LNSA) (an “Initial Holder”), the number of Warrants granted shall be equal to the Initial Holder’s Facility A Relevant Proportion of the number of Warrants determined by multiplying (i) the
quotient of (x) US$14,500,000 divided by (y) the Initial Share Price by (ii) the sum of 1 plus the quotient of (A) the Exercise Price (as defined below) divided by (B) the Initial Share Price. For each Holder that is an
Accordion Facility Lender (as defined in the LNSA) (an “Accordion Holder”), the number of Warrants granted shall be equal to the Accordion Holder’s Accordion Facility Relevant Proportion of the number of Warrants
determined by multiplying (i) the quotient of (x) US$966,667 divided by (y) the Initial Share Price by (ii) the sum of 1 plus the quotient of (A) the Exercise Price divided by (B) the Initial Share Price. Each Warrant
shall initially be exercisable for one Warrant Share, subject to adjustment as described in Sections 3.3.3 and 4 of the Warrant Agreement, and the terms and conditions of the Warrants issued to the Initial Holders and any Accordion Holders shall be
identical except for the issuance date. For the avoidance of doubt, the issuance date for a given Warrant shall be deemed to be the date specified in the instructions from the Company to the Warrant Agent instructing the issuance of such Warrant.

 (b) The Accordion Holder shall execute and deliver a written agreement to become a party to and to be bound by the terms and conditions
of this Agreement as a Holder granted Warrants hereunder, substantially in the form of the Counterpart Signature Page and Joinder attached as Exhibit A hereto. 

1.2 Terms and Exercise of Warrants. 

1.2.1 Exercise Price. Each Warrant shall, if a physical certificate is issued when countersigned by the Warrant Agent, entitle the
person or entity in whose name such Warrant is registered in the warrant register (the “Registered Holder”) thereof, subject to the provisions of such Warrant, the Warrant Agreement and of this Agreement, to subscribe for and
purchase from the Company the number the Warrant Shares stated therein, at the price of $0.0001 per share (the “Exercise Price”). 

1.2.2 Vesting and Expiration of Warrants. The vesting and expiration of the Warrants shall be in accordance with Section 3.2 of
the Warrant Agreement. 
 1.2.3 Exercise of Warrants. The exercise of the Warrants shall be effected in accordance with
Section 3.3 of the Warrant Agreement. 
 1.3 Adjustments to Number of Warrant Shares. In order to prevent dilution, the number
of Warrant Shares issuable upon exercise of the Warrants shall be subject to adjustment from time to time in accordance with Section 4 of the Warrant Agreement. 

1.4 Transfer and Exchange of Warrants. The transfer and exchange of the Warrants shall be effected in accordance with Section 5 of
the Warrant Agreement. 
 1.5 Redemption. The redemption of the Warrants shall be effected in accordance with Section 6 of the
Warrant Agreement. 
 1.6 Other Provisions Relating to the Warrants. The Warrants will be in all respects subject to the other terms
and conditions relating to the Warrants set forth in the Warrant Agreement. 

  
 2 

 ARTICLE II 

REGISTRATIONS 
 2.1
Registration. 
 2.1.1 Shelf Registration. (a) The Company agrees that, within forty-five (45) calendar days after
the Financial Close, the Company will file with the Commission (at the Company’s sole cost and expense) a Registration Statement registering the resale of all Registrable Securities (including any Registrable Securities eligible for
registration pursuant to Rule 416 or Rule 462(b) under the Securities Act) on a continuous basis pursuant to Rule 415 under the Securities Act (a “Shelf Registration”) and to the extent that the Company is eligible to file an
automatic shelf registration statement on Form F-3 ASR (an “Automatic Shelf Registration Statement”), the Shelf Registration shall be an Automatic Shelf Registration Statement that
includes the Warrant Adjustment Securities. 
 (b) The Company shall use its commercially reasonable efforts to cause such Registration
Statement to become effective by the Commission as soon as reasonably practicable after the initial filing of the Registration Statement but no later than the earlier of (a) the 60th calendar day (or 90th calendar day if the Commission notifies
the Company that it will conduct a full “review” the Registration Statement) following the Financial Close and (b) the tenth (10th) Business Day after the date the Company is
notified (orally or in writing, whichever is earlier) by the Commission that the Registration Statement will not be “reviewed” or will not be subject to further review (such earlier date, the “Effectiveness Date”)
and, in any event, shall use best efforts to cause the Registration Statement to be declared effective under the Securities Act within one year of the date of this Agreement; provided, however, that the Company’s obligations to include the
Registrable Securities in the Registration Statement are contingent upon Holder furnishing in writing to the Company such information regarding Holder, the securities of the Company held by Holder and the intended method of disposition of the
Registrable Securities as shall be reasonably requested by the Company to effect the registration of the Registrable Securities, and Holder shall execute a selling stockholder questionnaire in connection with such registration as the Registrable
Securities may reasonably request that is customary of a selling stockholder in similar situations; provided, that Holder shall not be required to execute any lock-up or similar agreement or otherwise
be subject to any contractual restriction on the ability to transfer the Registrable Securities except as provided for in Section 3.3. Subject to the limitations contained in this Agreement, the Company shall effect any
Shelf Registration on such appropriate registration form of the Commission (a) as shall be selected by the Company and (b) as shall permit the resale or other disposition of the Registrable Securities by the Holders. If at any time a
Registration Statement filed with the Commission pursuant to Section 2.1.1 is effective and a Holder provides written notice to the Company that it intends to effect an offering of all or part of the Registrable Securities
included on such Registration Statement, the Company will use its commercially reasonable efforts to amend or supplement such Registration Statement as may be necessary in order to enable such offering to take place in accordance with the terms of
this Agreement. Notwithstanding anything to the contrary herein, the Company shall not be required to include in any Shelf Registration any Warrant Adjustment Securities for so long as the Company is in compliance with the current public information
requirement under Rule 144(c)(1) promulgated under the Securities Act (or Rule 144(i)(2) promulgated under the Securities Act, if applicable). In the event Warrant Adjustment Securities are issued to the Holders subsequent to Financial Close and the
Company is not in compliance with the current public information requirement under Rule 144(c)(1) promulgated under the Securities Act (or Rule 144(i)(2) promulgated under the Securities Act, if applicable), the Holders shall be entitled to the
Shelf Registration rights in this Section 2.1.1 with respect to those Warrant Adjustment Securities; provided, that, the Company shall be able to effect such Shelf Registration using (i) a new Registration Statement, (ii) an
amendment or supplement to an existing Registration Statement or (iii) any combination thereof in the Company’s discretion and on the form the Company is then eligible to use that covers the most Registrable Securities (including to the
extent eligible the Warrant Adjustment Securities) in the following order of priority: (1) Form F-3 ASR, (2) Form F-3 and (3) Form F-1. The Company shall use its best efforts (x) to convert any Form F-1 relating to the Shelf Registration of the Registrable Securities to a Form F-3 as soon as practicable after the Company is eligible to use Form F-3 and (y) to file an automatic shelf registration statement on Form
F-3 ASR to cover the future issuances of Warrant Adjustment Securities as soon as practicable after the Company becomes a “well-known seasoned issuer” (as defined in Rule 405 under the Securities
Act). 
 2.1.2 [RESERVED] 

  
 3 

 2.2 Piggyback Registration. 

2.2.1 Piggyback Rights. If the Company proposes to (i) file a Registration Statement under the Securities Act with respect to the
Registration of equity securities of the Company, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities of the Company, for its own account or for the account of shareholders of the Company, other
than a Registration Statement (A) filed in connection with any employee stock option or other benefit plan, (B) pursuant to a Registration Statement on Form F-4 or
S-4 (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor rule thereto) (C) for an exchange offer or offering of securities solely to the
Company’s existing shareholders, (D) for an offering of debt that is convertible into equity securities of the Company or (E) for a dividend reinvestment plan, or (ii) consummate an Underwritten Offering for its own account or
for the account of shareholders of the Company (other than pursuant to the terms of this Agreement), then the Company shall give written notice of such proposed action to all of the Holders of Registrable Securities as soon as practicable (but in
the case of filing a Registration Statement, not less than ten (10) days before the anticipated filing date of such Registration Statement), which notice shall (x) describe the amount and type of securities to be included, the intended
method(s) of distribution and the name of the proposed managing Underwriter or Underwriters, if any, and (y) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable Securities as
such Holders may request in writing within (a) five (5) days in the case of filing a Registration Statement and (b) two (2) days in the case of an Underwritten Offering (unless such offering is an overnight or bought Underwritten
Offering, then one (1) day), in each case after receipt of such written notice (such Registration, a “Piggyback Registration”). The Company shall cause such Registrable Securities to be included in such Piggyback
Registration and shall use its commercially reasonable efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this
subsection 2.2.1 to be included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company included in such Piggyback Registration and to permit the sale or other
disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. If no written request for inclusion from a Holder is received within the specified time, each such Holder shall have no further right to
participate in such Piggyback Registration. All such Holders proposing to include Registrable Securities in an Underwritten Offering under this subsection 2.2.1 shall enter into an underwriting agreement in customary
form with the Underwriter(s) selected for such Underwritten Offering by the Company. 
 2.2.2 Reduction of Piggyback Registration. If
the managing Underwriter or Underwriters in an Underwritten Offering that is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the
dollar amount or number of shares of the equity securities of the Company that the Company desires to sell, taken together with (i) the shares of equity securities of the Company, if any, as to which Registration or Underwritten Offering has
been demanded pursuant to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (ii) the Registrable Securities as to which Registration or Underwritten Offering has been
requested pursuant to Section 2.2 of this Agreement and (iii) the shares of equity securities of the Company, if any, as to which Registration or Underwritten Offering has been requested pursuant to separate written
contractual piggyback registration rights of other shareholders of the Company, exceeds the Maximum Number of Securities, then: 
 (a) If
the Registration or Underwritten Offering is undertaken for the Company’s account, the Company shall include in any such Registration or Underwritten Offering (A) first, the Ordinary Shares or other equity securities of the Company that
the Company desires to issue, which can be issued without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A),
the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.1.1 of this Agreement (pro rata based on the respective number of Registrable Securities
that each Holder (if any) has requested be included in such Registration or Underwritten Offering and the aggregate number of Registrable Securities that all Holders have requested be included in such Registration or Underwritten Offering (such
proportion is referred to herein as “Pro Rata”)), which can be sold without exceeding the Maximum Number of Securities; and (C) third, to the extent that the Maximum Number of Securities has not been reached under the
foregoing clauses (A) and (B), Ordinary Shares or other equity securities of the Company, if any, as to which Registration or Underwritten Offering has been requested pursuant to written contractual piggyback
registration rights of other shareholders of the Company, which can be sold without exceeding the Maximum Number of Securities; or 

  
 4 

 (b) If the Registration or Underwritten Offering is pursuant to a demand by persons or
entities other than the Holders of Registrable Securities, then the Company shall include in any such Registration or Underwritten Offering (A) first, Ordinary Shares or other equity securities of the Company, if any, of such requesting persons
or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number of Securities; (B) second, to the extent that the Maximum Number of Securities has not been reached under the foregoing
clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.1.1 of this Agreement, Pro Rata, which can be sold
without exceeding the Maximum Number of Securities; (C) third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A) and (B), Ordinary Shares or other equity
securities of the Company that the Company desires to issue, which can be sold without exceeding the Maximum Number of Securities; and (D) fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing
clauses (A), (B) and (C), Ordinary Shares or other equity securities of the Company for the account of other persons or entities that the Company is obligated to register pursuant to separate written
contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of Securities. 
 2.2.3
Piggyback Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or
Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to, as applicable, the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration or the
launch of the Underwritten Offering with respect to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a request for withdrawal by persons or entities pursuant to separate written contractual
obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement or abandon an Underwritten Offering in connection with a
Piggyback Registration at any time prior to the launch of such Underwritten Offering. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the
Piggyback Registration prior to its withdrawal under this subsection 2.2.3. 
 2.3 [RESERVED] 

2.4 Restrictions on Registration Rights. If (A) the filing, initial effectiveness, or continued use of a Registration Statement at
any time would require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company’s control; or (B) in the good faith judgment of a majority of the Board, the
filing, initial effectiveness, or continued use of a Registration Statement would be seriously detrimental to the Company and the Board concludes as a result that it is essential to defer the filing, initial effectiveness or continued use of such
Registration Statement at such time, then in each case the Company shall furnish to such Holders a certificate signed by the Chairman of the Board stating that in the good faith judgment of the majority of the Board it would be seriously detrimental
to the Company for such Registration Statement to be filed, declared effective or continued to be used in the near future and that it is therefore essential to defer or discontinue the filing, initial effectiveness or continued use of such
Registration Statement. In such event, the Company shall have the right to defer or discontinue such filing or offering for a period of not more than thirty (30) days; provided, however, that the Company shall not defer its obligation in this
manner more than once in any twelve (12)-month period. 
 ARTICLE III 

COMPANY PROCEDURES 
 3.1
General Procedures. The Company shall use its commercially reasonable efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the
Company shall, as expeditiously as possible and to the extent applicable: 
 3.1.1 prepare and file with the Commission, within the time
frame required by Section 2.1.1, a Registration Statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such Registration Statement to become effective and remain
effective, including filing a replacement Registration Statement, if necessary, until all Registrable Securities covered by such Registration Statement have been sold or are no longer issued (such period, the “Effectiveness
Period”); 

  
 5 

 3.1.2 prepare and file with the Commission such amendments and post-effective amendments to
the Registration Statement, and such supplements to the Prospectus, as may be reasonably requested by the Holders or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the
Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such
Registration Statement or supplement to the Prospectus or are no longer issued; 
 3.1.3 prior to filing a Registration Statement or
Prospectus, or any amendment or supplement thereto, furnish without charge to the Holders of Registrable Securities included in such Registration or Underwritten Offering, and such Holders’ legal counsel, copies of such Registration Statement
as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus (including each preliminary Prospectus) and such
other documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders may reasonably request in order to facilitate the disposition of the Registrable Securities owned
by such Holders; provided, that the Company will not have any obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR system; 

3.1.4 prior to any Registration of Registrable Securities, use its commercially reasonable efforts to (i) register or qualify the
Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of
their intended plan of distribution) may request and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be
necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the
disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take
any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject; 

3.1.5 cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities
issued by the Company are then listed; 
 3.1.6 provide a transfer agent or warrant agent, as applicable, and registrar for all such
Registrable Securities no later than the effective date of such Registration Statement; 
 3.1.7 advise each seller of such Registrable
Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for
such purpose and promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued; 

3.1.8 during the Effectiveness Period, furnish a conformed copy of each filing of any Registration Statement or Prospectus or any amendment or
supplement to such Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration Statement or Prospectus, promptly after such filing of such documents with the Commission to each seller of such
Registrable Securities or its counsel; provided, that the Company will not have any obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR system; 

3.1.9 notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the
Securities Act; 
 3.1.10 in accordance with Section 3.4 of this Agreement of this Agreement, notify the Holders
of the happening of any event as a result of which a Misstatement exists, and then to correct such Misstatement as set forth in Section 3.4 of this Agreement; 

  
 6 

 3.1.11 in the event of an Underwritten Offering, permit a representative of the Holders
(such representative to be selected by a majority of the Holders), or the Underwriters facilitating such Underwritten Offering or other issue or sale pursuant to such Registration, if any, and any attorney, consultant or accountant retained by such
Holders or Underwriter to participate, at each such person’s or entity’s own expense, in the preparation of the Registration Statement or the Prospectus, and cause the Company’s officers, directors and employees to supply all
information reasonably requested by any such representative, Underwriter, attorney, consultant or accountant in connection with the Registration; provided, however, that such representatives or Underwriters enter to confidentiality
agreements, in form and substance reasonably satisfactory to the Company, prior to the release or disclosure of any such information; 

3.1.12 obtain a comfort letter from the Company’s independent registered public accountants in the event of an Underwritten Offering
pursuant to such Registration, in customary form and covering such matters of the type customarily covered by comfort letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders; 
 3.1.13 in the event of an Underwritten
Offering pursuant to such Registration, on the date the Registrable Securities are issued or delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel representing the Company for the purposes of such
Registration, addressed to the participating Holders, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the participating Holders or Underwriter may
reasonably request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to such participating Holders or Underwriter; 

3.1.14 in the event of an Underwritten Offering pursuant to such Registration to which the Company has consented, to the extent reasonably
requested by such Underwriter in order to engage in such offering, allow the Underwriters to conduct customary “underwriter’s due diligence” with respect to the Company; 

3.1.15 in the event of any Underwritten Offering pursuant to such Registration, enter into and perform its obligations under an underwriting
agreement or other subscription or purchase or sales agreement, in usual and customary form, with the managing Underwriter of such offering or sale; 

3.1.16 make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve
(12) months beginning with the first day of the Company’s first full semi-annual fiscal period after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and
Rule 158 thereunder (or any successor rule promulgated thereafter by the Commission); provided, that the Company will not have any obligation to provide any information pursuant to this clause that is available on the Commission’s
EDGAR system; 
 3.1.17 if the Registration involves the Registration of Registrable Securities in an Underwritten Offering, use its
reasonable efforts to make available senior executives of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and 

3.1.18 otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in
connection with such Registration. 
 Notwithstanding the foregoing, the Company shall not be required to provide any documents or information to an
Underwriter if such Underwriter has not then been named with respect to the applicable Underwritten Offering or other offering involving a registration as an Underwriter, as applicable. 

3.2 Registration Expenses. The Registration Expenses in respect of all Registrations shall be borne by the Company. It is acknowledged
by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set
forth in the definition of “Registration Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders. 

  
 7 

 3.3 Requirements for Participation in Underwritten Offerings. No person may
participate in any Underwritten Offering for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person (i) agrees to sell such person’s securities on the basis provided in any
underwriting arrangements approved by the Company and (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and other
customary documents as may be reasonably required under the terms of such underwriting arrangements. For the avoidance of doubt, no Holder shall be required to execute a lock-up agreement in order to
participate in an Underwritten Offering unless the managing Underwriter or Underwriters in an Underwritten Offering that is to be a Piggyback Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in
the Piggyback Registration in writing that such Holders’ failure to enter into a lock-up agreement would be seriously detrimental to the ability of the Underwriters and the Company to successfully execute
such Underwritten Offering, in which case such Holders shall be required to execute a lock-up agreement on substantially the same terms as similarly situated participants in such Underwritten Offering in order
to participate in such offering. 
 3.4 Suspension of Sales. Notwithstanding anything to the contrary in this Agreement, the Company
shall be entitled to (A) delay or postpone the (i) initial effectiveness of any Registration Statement or (ii) launch of any Underwritten Offering, in each case, filed or requested pursuant to this Agreement, and (B) from time to
time to require the Holders not to sell under any Registration Statement or Prospectus or to suspend the effectiveness thereof, if the negotiation or consummation of a transaction by the Company or its subsidiaries is pending or an event has
occurred, which negotiation, consummation or event, the Board reasonably believes, upon the advice of legal counsel, would require additional disclosure by the Company in the applicable Registration Statement or Prospectus of material information
that the Company has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Registration Statement or Prospectus would be expected, in the reasonable determination of the
Board, upon the advice of legal counsel, to cause the Registration Statement or Prospectus to fail to comply with applicable disclosure requirements (each such circumstance, a “Suspension Event”); provided, however, that the
Company may not delay or suspend a Registration Statement, Prospectus or Underwritten Offering on more than two occasions, for more than sixty (60) consecutive calendar days, or more than ninety (90) total calendar days, in each case
during any twelve-month period. Upon receipt of any written notice from the Company of a Suspension Event while a Registration Statement filed pursuant to this Agreement is effective or if as a result of a Suspension Event a Misstatement exists,
each Holder agrees that (i) it will immediately discontinue offers and sales of Registrable Securities under each Registration Statement filed pursuant to this Agreement until the Holder receives copies of a supplemental or amended Prospectus
(which the Company agrees to promptly prepare) that corrects the relevant misstatements or omissions and receives notice that any post-effective amendment has become effective or unless otherwise notified by the Company that it may resume such
offers and sales and (ii) it will maintain the confidentiality of information included in such written notice delivered by the Company unless otherwise required by law or subpoena. If so directed by the Company, the Holders will deliver to the
Company or, in Holders’ sole discretion destroy, all copies of each Prospectus covering Registrable Securities in Holders’ possession; provided, however, that this obligation to deliver or destroy shall not apply (A) to the extent the
Holders are required to retain a copy of such Prospectus (x) to comply with applicable legal, regulatory, self-regulatory or professional requirements or (y) in accordance with a bona fide
pre-existing document retention policy or (B) to copies stored electronically on archival servers as a result of automatic data back-up. 

3.5 Reporting Obligations. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a
reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
Section 13(a) or 15(d) of the Exchange Act. The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell shares of
Registrable Securities held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the
Commission), including providing any legal opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements. 

  
 8 

 ARTICLE IV 

INDEMNIFICATION AND CONTRIBUTION 

4.1 Indemnification. 

4.1.1 The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers and directors and
each person who controls such Holder (within the meaning of the Securities Act) (collectively, the “Holder Indemnified Persons”) against all losses, claims, damages, liabilities and out-of-pocket expenses (including reasonable outside attorneys’ fees and inclusive of all reasonable outside attorneys’ fees arising out of the enforcement of each such persons’ rights under
this Section 4.1) resulting from any Misstatement or alleged Misstatement, except insofar as the same are caused by or contained in any information furnished in writing to the Company by or on behalf of such Holder
Indemnified Person specifically for use therein. 
 4.1.2 In connection with any Registration Statement in which a Holder of Registrable
Securities is participating, such Holder shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus and, to the extent permitted
by law, shall, severally and not jointly, indemnify the Company, its directors and officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and out-of-pocket expenses (including reasonable outside attorneys’ fees and inclusive of all reasonable outside attorneys’ fees arising out of the enforcement of each
such persons’ rights under this Section 4.1) resulting from any Misstatement or alleged Misstatement, but only to the extent that the same are made in reliance on and in conformity with information relating to the
Holder so furnished in writing to the Company by or on behalf of such Holder specifically for use therein. In no event shall the liability of any selling Holder hereunder be greater in amount than the net proceeds received by such Holder from the
sale of Registrable Securities pursuant to such Registration Statement giving rise to such indemnification obligation. 
 4.1.3 Any person
entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any
person’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s reasonable judgment a conflict of interest between such
indemnified and indemnifying parties may exist with respect to such claim or there may be reasonable defenses available to the indemnified party that are different from or additional to those available to the indemnifying party, permit such
indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified
party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one
outside counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such
indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of
money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release
from all liability in respect to such claim or litigation. 
 4.1.4 The indemnification provided for under this Agreement shall remain in
full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the transfer of securities. 

4.1.5 If the indemnification provided under Section 4.1 of this Agreement is held by a court of competent
jurisdiction to be unavailable to an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall to the extent permitted
by law contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the
indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by a court of law by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by such indemnifying party or such indemnified party and the indemnifying party’s and indemnified party’s
relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this subsection 4.1.5 shall be limited to the
amount of the net proceeds received by such Holder in such offering giving rise to such liability. The 

  
 9 

 
amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in
subsections 4.1.1, 4.1.2 and 4.1.3 of this Agreement, any legal or other fees, charges or out-of-pocket expenses
reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this subsection 4.1.5 were determined
by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this subsection 4.1.5. No person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this subsection 4.1.5 from any person who was not guilty of such fraudulent misrepresentation. 

ARTICLE V 

MISCELLANEOUS 
 5.1
Notices. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt
requested, (ii) delivery in person or by courier service providing evidence of delivery or (iii) transmission by hand delivery, telecopy, telegram, facsimile or email. Each notice or communication that is mailed, delivered or transmitted
in the manner described above shall be deemed sufficiently given, served, sent, and received, in the case of mailed notices, on the third (3rd) Business Day following the date on which it is mailed, in the case of notices delivered by courier
service, hand delivery, telecopy or telegram, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation, and in the case of
notices delivered by facsimile or email, at such time as it is successfully transmitted to the addressee. Any notice or communication under this Agreement must be addressed, if to the Company, to: 48 Miller Street, MURARRIE, QLD 4172, Australia,
Attention: Michael Collins, or by email at: mcollins@tritium.com.au, and, if to any Holder, to the address of such Holder as it appears in the applicable register for the Registrable Securities or such other address as may be designated in writing
by such Holder (including on the signature pages hereto). Any party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty
(30) days after delivery of such notice as provided in this Section 5.1. 
 5.2 Assignment; No Third Party
Beneficiaries. 
 5.2.1 This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated
by the Company in whole or in part. 
 5.2.2 This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit
of each of the parties and its successors. 
 5.2.3 This Agreement shall not confer any rights or benefits on any persons that are not
parties hereto or do not hereafter become a party to this Agreement pursuant to Section 5.2 of this Agreement. 

5.2.4 No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the
Company unless and until the Company shall have received (i) written notice provided in accordance with Section 5.1 of this Agreement and (ii) the written agreement of the assignee to become a party to and to be
bound by the terms and conditions of this Agreement as a Holder granted Warrants hereunder, substantially in the form of the Counterpart Signature Page and Joinder attached as Exhibit A hereto. Any transfer or assignment made other than as
provided in this Section 5.2 shall be null and void. 
 5.3 Counterparts. This Agreement may be executed in
multiple counterparts (including executed manually or electronically via DocuSign or other similar services and delivered via facsimile or PDF counterparts), each of which shall be deemed an original, and all of which together shall constitute the
same instrument, but only one of which need be produced. 
 5.4 Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT
MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE
PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION. 

  
 10 

 5.5 Amendments and Modifications. Upon the written consent of the Company and the
Holders of at least a majority in interest of the total Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants
or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in his, her or its capacity as a holder of the shares of capital
stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No course of dealing between any Holder or the Company and any other party hereto or any
failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or
remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party. 

5.6 Other Registration Rights. The Company represents and warrants that no person, other than (a) the holders that are named in
the Amended and Restated Registration Rights Agreement, dated January 13, 2022, by and among the Company, the SPAC, and the other parties thereto, (b) the holders of the Company’s warrants pursuant to that certain Warrant Agreement,
dated as of February 3, 2021, by and between the SPAC and Continental Stock Transfer & Trust Company, and assigned to and assumed by the Company, Computershare Inc. and its wholly owned subsidiary, Computershare Trust Company, N.A., on
or about January 13, 2022, and (c) Palantir Technologies Inc., pursuant to its Amended and Restated Subscription Agreement with the Company and the SPAC, dated as of January 31, 2022, and (d)(i) entities affiliated with St Baker
Energy Holdings Pty Ltd, (ii) Varley Holdings Pty Ltd, (iii) Ilwella Pty Ltd and (iv) Decarbonization Plus Acquisition Sponsor II LLC (together, the “Option Holders”), pursuant to the option agreements entered
into with each of the Option Holders and the Company, each dated as of January 13, 2022, has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration
filed by the Company for the issue or sale of securities for its own account or for the account of any other person. 
 5.7 Term.
This Agreement shall terminate, with respect to any Holder, upon the date as of which such Holder ceases to hold any Registrable Securities. The provisions of Article IV shall survive any termination. 

5.8 Foreign Private Issuer Status. If the Company ceases to be a “foreign private issuer” (as defined in Rule 405 of the
Securities Act) eligible to use a registration statement on Form F-1, Form F-3 or Form F-3 ASR, as the case may be, then all
references in this Agreement to any such form shall be deemed to be references to Form S-1, Form S-3 or Form S-3 ASR, as
applicable, or such similar or successor form as may be appropriate. 
 ARTICLE VI 

REPRESENTATIONS AND WARRANTIES 

6.1 Company Representations and Warranties. The Company represents and warrants that: 

6.1.1 The Company is a corporation registered and validly existing under the Corporations Act, with corporate power and authority to own, lease
and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform its obligations under this Agreement. 

6.1.2 The Holder will subscribe for and acquire on each Share Issue Date the full legal and beneficial ownership of the applicable Warrant
Shares which shall be (i) free and clear of all encumbrances, subject to the registration of the Holder in the register of shareholders; (ii) duly authorized by all necessary corporation action on the part of the Company prior to the
relevant Exercise Date and validly issued by the Company; (iii) free of competing rights, including pre-emptive rights or rights of first refusal; and (iv) fully paid and have no money owing in
respect of them (assuming full payment therefor in accordance with the terms of this Agreement). 

  
 11 

 6.1.3 This Agreement has been duly authorized, executed and delivered by the Company and
constitutes the valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance,
reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law or equity. 

6.1.4 Assuming the accuracy of each Holder’s representations and warranties set forth in Section 6.2 of this Agreement, the
execution and delivery by the Company of this Agreement, and the performance by the Company of its obligations under this Agreement, including the grant of the Warrant and issuance of the Warrant Shares and the consummation of the other transactions
contemplated herein and therein do not and will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon
any of the property or assets of the Company pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which the Company is a party or by which the Company is bound
or to which any of the property or assets of the Company is subject, which would reasonably be expected to have, individually or in the aggregate, a material adverse effect on the business, properties, financial condition, shareholders’ equity
or results of operations of the Company (a “Material Adverse Effect”) or materially affect the validity of the Warrant or the Warrant Shares or the legal authority of the Company to comply in all material respects with the
terms of this Agreement; (ii) the constitution of the Company as amended or varied from time to time (the “Constitution”) or other organizational documents (as applicable) of the Company; or (iii) any statute or any
judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Company or any of its properties that would reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect or materially affect the validity of the Warrant or the Warrant Shares or the legal authority of the Company to comply in all material respects with this Agreement. 

6.1.5 Other than the Company’s issued public warrants and private placement warrants to subscribe for and purchase Ordinary Shares, there
are no securities or instruments issued by or to which the Company is a party containing anti-dilution or similar provisions that will be triggered by the issuance of the Warrant or the Warrant Shares that have not been validly waived. 

6.1.6 Assuming the accuracy of each Holder’s representations and warranties set forth in Section 6.2 of this Agreement, the Company
is not in default or violation (and no event has occurred which, with notice or the lapse of time or both, would constitute a default or violation) of any term, condition or provision of (i) the Constitution, (ii) any loan or credit
agreement, guarantee, note, bond, mortgage, indenture, lease or other agreement, permit, franchise or license to which the Company is now a party or by which the Company’s properties or assets are bound or (iii) any statute or any
judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Company or any of its properties, except, in the case of clauses (ii) and (iii), for defaults or violations that
have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 
 6.1.7 Assuming
the accuracy of each Holder’s representations and warranties set forth in Section 6.2 of this Agreement, the Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the execution, delivery and performance by the Company of this Agreement (including, without
limitation, the issuance of the Warrant and the Warrant Shares), other than (i) the filing with the Commission of the registration statement, (ii) filings required by applicable U.S. state or federal or Australian securities laws,
(iii) filings required by the Exchange Act, and (iv) consents or filings, the failure of which to obtain or file would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or have a material
adverse effect on the Company’s ability to consummate the transactions contemplated hereby, including the sale and issuance of the Warrant and the Warrant Shares. 

6.1.8 As of the date of this Agreement, the Company has the share capital and outstanding indebtedness described in the SEC Documents (as
defined below) or as otherwise disclosed by the Company. All issued Ordinary Shares have been duly authorized and validly issued, are fully paid and are not subject to any call for payment of further capital (subject to full payment therefor in
accordance with the terms of this Agreement) and are not subject to preemptive rights. Except as described in the SEC Documents or as otherwise disclosed by the Company, 

  
 12 

 
there are no issued options, warrants or other rights to subscribe for, purchase or acquire from the Company any Ordinary Shares or other equity interests in the Company, or securities
convertible into or exchangeable or exercisable for such equity interests. As of the date hereof, the Company has no subsidiaries (other than the subsidiaries set forth on Schedule 6.1.8 attached hereto) and does not own, directly or indirectly,
interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated. There are no shareholder agreements, voting trusts or other agreements or understandings to which the Company is a party or by which it is bound
relating to the voting of any securities of the Company, other than as set forth in the SEC Documents or as otherwise disclosed by the Company. 

6.1.9 The Company has not received any written communication from a governmental entity alleging that the Company is not in compliance with or
is in default or violation of any applicable law, except where such non-compliance, default or violation would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 6.1.10 Assuming the accuracy of each Holder’s representations and warranties set forth in Section 6.2 of this Agreement, no
registration under the Securities Act is required for the offer and sale of the Warrant or the Warrant Shares by the Company to such Holder in the manner contemplated by this Agreement. 

6.1.11 Neither the Company nor any person acting on its behalf has engaged or will engage in any form of general solicitation or general
advertising (within the meaning of Regulation D of the Securities Act) in connection with any offer or sale of the Warrant and the Warrant Shares. 

6.1.12 There is no (i) suit, action, proceeding, or arbitration pending, or, to the Company’s knowledge, threatened against the
Company or (ii) judgment, decree, injunction, ruling or order of any governmental entity or arbitrator outstanding against the Company, except for such matters as have not had and would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect. 
 6.1.13 The Company has not paid, and is not obligated to pay, any brokerage, finder’s or other
commission or similar fee in connection with its issuance and sale of the Warrant or the Warrant Shares. 
 6.1.14 None of the Company, its
subsidiaries or any of their affiliates, nor any person acting on their behalf has, directly or indirectly, made any offers of any security or solicited any offers to buy any security, under circumstances that would require registration of the
issuance of any of the Warrant or the Warrant Shares under the Securities Act, whether through integration with prior offerings pursuant to Rule 502(a) of the Securities Act or otherwise. 

6.1.15 The Company and its affiliates will not directly or indirectly use the proceeds from the exercise of the Warrant or issuance of any
Warrant Shares, or lend, contribute or otherwise make available such proceeds to a subsidiary, joint venture partner or other person or entity (i) to fund a person or entity named on an OFAC List, (ii) that is owned or controlled by, or
acting on behalf of, a person, that is named on an OFAC List, (iii) that is organized, incorporated, established, located, resident or born in, or a citizen, national, or the government, including any political subdivision, agency, or
instrumentality thereof, of, Cuba, Iran, North Korea, Syria, the Donetsk, Luhansk and Crimea regions of Ukraine, or any other country or territory embargoed or subject to substantial trade restrictions by the United States, (iv) that is a
Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515 or (v) that is a non-U.S. shell bank or providing banking services indirectly to a
non-U.S. shell bank. 
 6.1.16 The Company is not, and immediately after receipt of payment by the
Company for the Warrant Shares will not be, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 

6.1.17 The Company has made available to the Holder (including via the Commission’s EDGAR system) a copy of each form, report, statement,
schedule, prospectus, proxy, registration statement and other document, if any, filed by the Company with the Commission since the first date on which any class of securities of the Company was registered with the Commission, if any (the
“SEC Documents”), which SEC Documents, as of their 

  
 13 

 
respective filing dates, complied in all material respects with the applicable requirements of the Exchange Act, Securities Act, and the applicable rules and regulations of the Commission
promulgated thereunder. None of the SEC Documents filed under the Exchange Act (except to the extent that information contained in any SEC Document has been superseded by a later timely filed SEC Document) contained, when filed, any untrue statement
of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading, in the case of any SEC Document that is a registration statement, or included, when filed, any untrue
statement of a material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, in the case of all other SEC Documents. The Company has timely
filed each report, statement, schedule, prospectus, and registration statement that the Company was required to file with the Commission since its inception. There are no material outstanding or unresolved comments in comment letters from the staff
of the Commission with respect to any of the SEC Documents. 
 6.2 Holder Representations and Warranties. Each Holder represents and
warrants to the Company in respect of itself and not any other Holder that: 
 6.2.1 Holder has been duly formed or incorporated and is
validly existing in good standing under the laws of its jurisdiction of incorporation or formation, with the requisite entity power and authority to enter into, deliver and perform its obligations under this Agreement. 

6.2.2 This Agreement has been duly authorized, executed and delivered by Holder. This Agreement is enforceable against Holder in accordance
with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, and (ii) principles
of equity, whether considered at law or equity. 
 6.2.3 No consent, approval, order or authorization of, or registration, qualification,
designation, declaration or filing with, any federal, state or local governmental authority is required on the part of Holder in connection with the consummation of the transactions contemplated by this Agreement. 

6.2.4 The execution and delivery by Holder of this Agreement, and the performance by Holder of its obligations under this Agreement, including
accepting the grant of the Warrant, the subscription for and purchase of the Warrant Shares and the consummation of the other transactions contemplated herein will not conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of Holder or any of its subsidiaries pursuant to the terms of (i) any indenture,
mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which Holder or any of its subsidiaries is a party or by which Holder or any of its subsidiaries is bound or to which any of the property or assets of Holder
or any of its subsidiaries is subject, which would reasonably be expected to have a material adverse effect on the business, properties, financial condition, shareholders’ equity or results of operations of Holder and any of its subsidiaries,
taken as a whole (a “Holder Material Adverse Effect”), or materially affect the legal authority of Holder to comply in all material respects with the terms of this Agreement; (ii) the organizational documents of Holder;
or (iii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over Holder or any of its subsidiaries or any of their respective properties that would
reasonably be expected to have a Holder Material Adverse Effect or materially affect the legal authority of Holder to comply in all material respects with this Agreement. 

6.2.5 Holder (i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an
institutional “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) (5), (6), (7), (10), (11) or (12) under the Securities Act), (ii) is acquiring the Warrant and, to the extent exercised, the Warrant
Shares, only for its own account, or if Holder is acquiring the Warrant and the Warrant Shares as a fiduciary or agent for one or more investor accounts, each owner of such account is a “qualified institutional buyer” or an institutional
“accredited investor” (each as defined above) and Holder has full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations and agreements herein on behalf of
each owner of each such account, and (iii) is not acquiring the Warrant or, to the extent exercised, the Warrant Shares, with a view to, or for offer or sale in connection with, any distribution thereof in violation of the Securities Act or the
Corporations Act. 

  
 14 

 6.2.6 Holder understands that the Warrant and the Warrant Shares are being offered in a
transaction not involving any public offering within the meaning of the Securities Act and that the Warrant and the Warrant Shares have not been registered under the Securities Act. Holder understands that the Warrant and the Warrant Shares may not
be resold, transferred, pledged or otherwise disposed of by Holder absent an effective registration statement under the Securities Act, except (i) to the Company or a subsidiary thereof, (ii) to
non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act and in compliance with all applicable laws, (iii) pursuant to
Rule 144 under the Securities Act, provided that all of the applicable conditions thereof have been met or (iv) pursuant to another applicable exemption from the registration requirements of the Securities Act. Holder acknowledges that the
Warrant Shares will not be eligible for resale pursuant to Rule 144A promulgated under the Securities Act. Holder understands and agrees that the Warrant Shares will be subject to the foregoing restrictions and, as a result, Holder may not be able
to readily resell the Warrant Shares and may be required to bear the financial risk of an investment in the Warrant Shares for an indefinite period of time. Holder understands that it has been advised to consult legal counsel prior to making any
offer, resale, pledge or transfer of the Warrant Shares. 
 6.2.7 Holder understands and agrees that Holder is subscribing for and
purchasing the Warrant and the Warrant Shares directly from the Company and Holder consents to become a member of the Company. This Agreement serves as an application by the Holder for the allotment of Ordinary Shares subscribed for and purchased
under this Agreement on the applicable Share Issue Date and accordingly it will not be necessary for the Holder to provide a separate (additional) application on or prior to the applicable Share Issue Date for those Ordinary Shares. Holder agrees to
be bound by the Constitution upon the issue to the Holder of any Ordinary Shares. Holder further acknowledges that there have been no representations, warranties, covenants and agreements made to Holder by the Company or any of its officers or
directors, expressly or by implication, other than those representations, warranties, covenants and agreements included in this Agreement. 

6.2.8 Holder’s acquisition and holding of the Warrant and the Warrant Shares will not constitute or result in a non-exempt prohibited transaction under section 406 of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), section 4975 of the Internal Revenue Code of 1986, as amended
(the “Code”), or any applicable similar law. 
 6.2.9 In making its decision to accept the grant of the Warrant and
subscribe for and purchase, to the extent exercised, the Warrant Shares, Holder represents that it has relied solely upon its own independent investigation. Holder acknowledges and agrees that Holder has received and has had the opportunity to
review such information and documents as Holder deems necessary to make an investment decision with respect to the Warrant and the Warrant Shares. Holder represents and agrees that Holder and Holder’s professional advisor(s), if any, have had
the full opportunity to ask such questions, receive such answers and obtain such information as Holder and such Holder’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Warrant and the
Warrant Shares. 
 6.2.10 Holder became aware of this offering of the Warrant and the Warrant Shares solely by means of direct contact
between Holder and the Company or a representative of the Company, and the Warrant and the Warrant Shares were offered to Holder solely by direct contact between Holder and the Company or a representative of the Company. Holder acknowledges that the
Company represents and warrants that the Warrant and the Warrant Shares (i) were not offered by any form of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under, or in a
distribution in violation of, the Securities Act, any state securities laws or any applicable laws of any other jurisdiction. 
 6.2.11
Holder acknowledges that it is aware that there are substantial risks incident to the subscription for, purchase and ownership of the Warrant and the Warrant Shares. Holder is a sophisticated investor and is able to fend for itself in the
transactions contemplated herein, has exercised its independent judgment in evaluating its investment in the Warrant and the Warrant Shares, has such knowledge and experience in financial, business and tax matters as to be capable of evaluating the
merits, risks and uncertainties inherent in an investment in the Warrant and the Warrant Shares, and Holder has sought such accounting, legal, economic and tax advice as Holder has considered necessary to make an informed investment decision. 

  
 15 

 6.2.12 Alone, or together with any professional advisors, Holder represents and acknowledges
that Holder has adequately analyzed and fully considered and assumed the risks of an investment in the Warrant and the Warrant Shares and determined that the Warrant and the Warrant Shares are a suitable investment for Holder and that Holder is able
at this time and in the foreseeable future to bear the economic risk of a total loss of Holder’s investment in the Company. Holder acknowledges specifically that a possibility of total loss exists. 

6.2.13 Holder understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Warrant or
the Warrant Shares or made any findings or determination as to the fairness of an investment in the Warrant or the Warrant Shares. 
 6.2.14
If Holder is or is acting on behalf of (i) an employee benefit plan that is subject to Title I of ERISA, (ii) a plan, an individual retirement account or other arrangement that is subject to section 4975 of the Code, (iii) an entity
whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement described in clauses (i) and (ii) (each, an “ERISA Plan”), or (iv) an employee benefit plan that is
a governmental plan (as defined in section 3(32) of ERISA), a church plan (as defined in section 3(33) of ERISA), a non-U.S. plan (as described in section 4(b)(4) of ERISA) or other plan that is not subject to
the foregoing clauses (i), (ii) or (iii) but may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the
Code (collectively, “Similar Laws,” and together with the ERISA Plans, “Plans”), Holder represents and warrants that (i) neither the Company nor its respective affiliates (the
“Transaction Parties”) has provided investment advice or has otherwise acted as the Plan’s fiduciary, with respect to its decision to subscribe for and acquire and hold the Warrant Shares, and none of the Transaction
Parties is or shall at any time be the Plan’s fiduciary with respect to any decision to subscribe for and acquire and hold the Warrant Shares, and none of the Transaction Parties is or shall at any time be the Plan’s fiduciary with respect
to any decision in connection with Holder’s investment in the Warrant Shares; and (ii) its subscription for and purchase of the Warrant Shares will not result in a non-exempt prohibited transaction
under section 406 of ERISA or section 4975 of the Code, or any applicable Similar Law. 
 6.2.15 If Holder is located in the United Kingdom
or a member state of the European Economic Area, it represents and warrants that it is a qualified investor (within the meaning of Regulation (EU) 2017/1129). 

6.2.16 If the Holder is located in Australia, the Holder represents and warrants that it is a person who falls within an exempt offer category
in section 708 of the Corporations Act (including “sophisticated investors” or “professional investors” within the meaning of section 708(8) and 708(11) respectively of the Corporations Act). 

6.2.17 If Holder is located in the United Kingdom, Holder represents and warrants that it is a person of a kind described in articles 19(5) or
49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or is otherwise a person to whom an invitation or inducement to engage in investment activity may be communicated without contravening
section 21 of the Financial Services and Markets Act 2000. 
 ARTICLE VII 

CERTAIN DEFINITIONS 
 7.1
Definitions. The terms defined in this Section 7.1 shall, for all purposes of this Agreement, have the respective meanings set forth below: 

“Accordion Facility Effective Date” shall have the meaning given in the LNSA. 

“Accordion Facility Lender” shall have the meaning given in the LNSA. 

“Accordion Facility Relevant Proportion” means, in relation to an Accordion Holder, the proportion of Accordion
Facility Commitments (as defined in the LNSA) that such Accordion Holder makes available under the LNSA as it bears to the Total Accordion Facility Commitments (as defined in the LNSA) made available under the LNSA as at such date. 

  
 16 

 “Board” shall mean the board of directors of the Company. 

“Business Day” shall mean a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City and
Brisbane are generally open for normal business. 
 “Commission” shall mean the Securities and Exchange Commission.

 “Exchange Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time. 

“Facility A Lender” shall have the meaning given in the LNSA. 

“Facility A Relevant Proportion” means, in relation to an Initial Holder, the proportion of Facility A Commitments (as
defined in the LNSA) that such Initial Holder makes available under the LNSA as it bears to the Total Facility A Commitments (as defined in the LNSA) made available under the LNSA as at such date. 

“Financial Close” shall have the meaning given in the LNSA. 

“Maximum Number of Securities” shall mean the maximum dollar amount or maximum number of equity securities of the
Company that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution method or the probability of success of such offering. 

“Misstatement” shall mean an untrue statement of a material fact or an omission to state a material fact required to
be stated in a Registration Statement or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the light of the circumstances under which they were made) not misleading. 

“OFAC Lists” means, collectively, the List of Specially Designated Nationals and Blocked Persons, the Executive Order
13599 List, the Foreign Sanctions Evaders List, or the Sectoral Sanctions Identification List, each of which is administered by the U.S. Treasury Department’s Office of Foreign Assets Control. 

“Person” means any individual, sole proprietorship, partnership, limited liability company, corporation, joint
venture, trust, incorporated organization or government or department or agency thereof. 
 “Prospectus” shall mean
the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus. 

“Registrable Securities” shall mean (a) the Warrants, (b) any Warrant Shares issued or issuable upon the
exercise of any such Warrants, and (c) any other equity security of the Company issued or issuable with respect to any such Warrant Shares held by a Holder immediately following the Financial Close by way of a share sub-division or share dividend or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; provided, however, that, as to any particular Registrable
Securities, such securities shall cease to be Registrable Securities when: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold,
transferred, disposed of or exchanged in accordance with such Registration Statement; (B) such securities shall have been otherwise transferred and have been recorded by the Company’s transfer agent in book-entry form not bearing a legend
restricting further transfer and subsequent public distribution of such securities shall not require registration under the Securities Act; (C) such securities shall have ceased to be issued by the Company; or (D) such securities may be
sold without registration pursuant to Rule 144 promulgated under the Securities Act (or any successor rule promulgated thereafter by the Commission) without the requirement for the Company to be in compliance with the current public information
requirement under Rule 144(c)(1) promulgated under the Securities Act (or Rule 144(i)(2) promulgated under the Securities Act, if applicable). 

“Registration” shall mean a registration effected by preparing and filing a registration statement or similar document
in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and any such registration statement having been declared effective by, or become effective pursuant to rules promulgated by,
the Commission. 

  
 17 

 “Registration Expenses” shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following: 

(A) all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory
Authority and any securities exchange on which the Ordinary Shares is then listed); 
 (B) fees and expenses of compliance with securities
or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities); 

(C) printing, messenger, telephone and delivery expenses; 

(D) reasonable fees and disbursements of counsel for the Company; 

(E) reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with
such Registration; 
 (F) reasonable fees and expenses of one (1) legal counsel selected by the majority-in-interest of Registrable Securities held by the holders pursuant to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder,
not to exceed US$50,000; and 
 (G) reasonable fees and expenses of one (1) legal counsel selected by the majority-in-interest of Registrable Securities held by the Holders hereunder, not to exceed US$25,000. 

“Registration Statement” shall mean any registration statement under the Securities Act that covers the Registrable
Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all
material incorporated by reference in such registration statement. 
 “Securities Act” shall mean the Securities Act
of 1933, as amended from time to time. 
 “SPAC” shall mean Decarbonization Plus Acquisition Corporation II, a
Delaware corporation. 
 “Underwriter” shall mean a securities dealer who subscribes for and purchases any
Registrable Securities as principal in an Underwritten Offering and not as part of such dealer’s market-making activities. 

“Underwritten Offering” shall mean a Registration in which securities of the Company are issued or sold to an
Underwriter in a firm commitment underwriting for distribution to the public. 
 “Warrant Adjustment Securities”
shall mean any Registrable Securities issued to the Holders subsequent to the Financial Close pursuant to the warrant adjustments contemplated in Section 3.3.3 (Guaranteed Value) and Section 4 (Adjustments to Number of Warrant Shares) of
the Warrant Agreement, other than such Registrable Securities that are eligible for registration (x) pursuant to Rule 416 or 462(b) under the Securities Act or (y) on an Automatic Shelf Registration Statement. 

[SIGNATURE PAGES FOLLOW] 

  
 18 

 IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of
the date first written above. 
  

			
	COMPANY:
	
	 TRITIUM DCFC LIMITED,
 an
Australian public company in accordance with section 127 of the Corporations Act 2001 (Cth)

		
	By:	 	/s/ Jane Hunter
		 	 Name: Jane Hunter
 Title: Chief Executive
Officer and Director

  

			
	By:	 	/s/ Michael R. Collins
		 	 Name: Michael R. Collins
 Title: General
Counsel and Corporate Secretary

 [Signature Page to Subscription and Registration Rights Agreement] 

			
	 HOLDER:
  

CIGNA HEALTH AND LIFE INSURANCE COMPANY
  
	  	
	By: CIGNA INVESTMENTS, INC. (authorized agent)	  	Number of Warrants: 541,558
		
	Signature of Holder	  	Signature of Joint Holder, if applicable:
		
	/s/ Kevin Pattison	  	 
		
	By:	  	By:
		
	 Name: Kevin Pattison
  

Title: Managing Director
	  	 Name:
  

Title:

		
	Date: September 1, 2022	  	
		
	Name of Holder: Cigna Health and Life Insurance Company	  	Name of Joint Holder, if applicable:
		
	 	  	 
	(Please print. Please indicate name and capacity of person signing above)	  	(Please print. Please indicate name and capacity of person signing above)
		
	 Name in which securities are to be registered (if different):
  

Email Address: [REDACTED]
  

If there are joint investors, please check one:
  

☐ Joint Tenants with Rights of Survivorship
  

☐ Tenants-in-Common

 
 ☐ Community Property

 
	  	Notice address (pursuant to Section 5.1 of this Agreement):
		
	 Holder’s EIN: [REDACTED]
  

Business Address-Street: c/o Cigna Investments, Inc.
	  	 Joint Holder’s EIN:
  

Mailing Address-Street (if different)

		
	900 Cottage Grove Road, A5PRI	  	 
		
	Hartford, CT 06152	  	 
	 City, State, Zip:
  

Attn:
  

Telephone No.: [REDACTED]
  

Facsimile No.:
	  	 City, State, Zip:
  

Attn:
  

Telephone No.:
  

Facsimile No.:

 [Signature Page to Subscription and Registration Rights Agreement] 

			
	 HOLDER:
  

HEALTHSPRING LIFE & HEALTH INSURANCE COMPANY, INC.
	  	
		
	By: CIGNA INVESTMENTS, INC. (authorized agent)	  	Number of Warrants: 406,168
		
	Signature of Holder	  	Signature of Joint Holder, if applicable:
		
	/s/ Kevin Pattison	  	 
		
	By:	  	By:
		
	 Name: Kevin Pattison
  

Title: Managing Director
	  	 Name:
  

Title:

		
	Date: September 1, 2022	  	
		
	Name of Holder: Healthspring Life & Health Insurance Company, Inc.	  	Name of Joint Holder, if applicable:
		
	 	  	 
	(Please print. Please indicate name and capacity of person signing above)	  	(Please print. Please indicate name and capacity of person signing above)
		
	 Name in which securities are to be registered (if different):
  

Email Address: [REDACTED]
  

If there are joint investors, please check one:
  

☐ Joint Tenants with Rights of Survivorship
  

☐ Tenants-in-Common

 
 ☐ Community Property
	  	Notice address (pursuant to Section 5.1 of this Agreement):
		
	 Holder’s EIN: [REDACTED]
  

Business Address-Street: c/o Cigna Investments, Inc.
	  	 Joint Holder’s EIN:
  

Mailing Address-Street (if different)

	900 Cottage Grove Road, A5PRI	  	 
	Hartford, CT 06152	  	 
	 City, State, Zip:
  

Attn:
  

Telephone No.: [REDACTED]
  

Facsimile No.:
	  	 City, State, Zip:
  

Attn:
  

Telephone No.:
  

Facsimile No.:

 [Signature Page to Subscription and Registration Rights Agreement] 

			
	HOLDER: BARINGS TARGET YIELD INFRASTRUCTURE DEBT HOLDCO 1 S.À R.L.	  	
		
	Acting by its attorney Barings LLC acting by	  	Number of Warrants: 609,252
		
	Signature of Holder	  	Signature of Joint Holder, if applicable:
		
	/s/ Patrick Mansean	  	 
		
	By:	  	By:
		
	 Name: Patrick Mansean
  

Title: Managing Director
	  	 Name:
  

Title:

		
	Date: September 1, 2022	  	
		
	Name of Holder: Barings Target Yield Infrastructure Debt Holdco 1 S.À R.L	  	Name of Joint Holder, if applicable:
		
	 	  	 
	(Please print. Please indicate name and capacity of person signing above)	  	(Please print. Please indicate name and capacity of person signing above)
		
	 Name in which securities are to be registered (if different):
  

Email Address:
  

If there are joint investors, please check one:
  

☐ Joint Tenants with Rights of Survivorship
  

☐ Tenants-in-Common

 
 ☐ Community Property
	  	Notice address (pursuant to Section 5.1 of this Agreement):
		
	 Holder’s EIN: [REDACTED]
  

Business Address-Street: c/o Barings LLC
	  	 Joint Holder’s EIN:
  

Mailing Address-Street (if different)

	300 S. Tryon St., Suite 2500	  	 
	Charlotte, North Carolina 28202	  	 
	 City, State, Zip:
  

Attn: Mark Ackerman
  

Telephone No.: [REDACTED]
  

Facsimile No.:
	  	 City, State, Zip:
  

Attn:
  

Telephone No.:
  

Facsimile No.:

 [Signature Page to Subscription and Registration Rights Agreement] 

			
	HOLDER: MARTELLO RE LIMITED	  	
		
	Acting by its attorney Barings LLC acting by	  	Number of Warrants: 338,473
		
	Signature of Holder	  	Signature of Joint Holder, if applicable:
		
	/s/ Patrick Mansean	  	 
		
	By:	  	By:
		
	 Name: Patrick Mansean
  

Title: Managing Director
	  	 Name:
  

Title:

		
	Date: September 1, 2022	  	
		
	Name of Holder: Martello Re Limited	  	Name of Joint Holder, if applicable:
		
	 	  	 
	(Please print. Please indicate name and capacity of person signing above)	  	(Please print. Please indicate name and capacity of person signing above)
		
	 Name in which securities are to be registered (if different):
  

Email Address:
  

If there are joint investors, please check one:
  

☐ Joint Tenants with Rights of Survivorship
  

☐ Tenants-in-Common

 
 ☐ Community Property
	  	Notice address (pursuant to Section 5.1 of this Agreement):
		
	 Holder’s EIN: [REDACTED]
  

Business Address-Street: c/o Barings LLC
	  	 Joint Holder’s EIN:
  

Mailing Address-Street (if different)

	300 S. Tryon St., Suite 2500	  	 
	Charlotte, North Carolina 28202	  	 
	 City, State, Zip:
  

Attn: Mark Ackerman
  

Telephone No.: [REDACTED]
  

Facsimile No.:
	  	 City, State, Zip:
  

Attn:
  

Telephone No.:
  

Facsimile No.:

 [Signature Page to Subscription and Registration Rights Agreement] 

			
	HOLDER: REL BATAVIA PARTNERSHIP, L.P.	  	
		
	By Riverstone Holdings, LLC, as Investment Manager	  	Number of Warrants: 135,389
		
	Signature of Holder	  	Signature of Joint Holder, if applicable:
		
	/s/ Peter Haskopoulos	  	 
		
	By:	  	By:
		
	 Name: Peter Haskopoulos
  

Title: Authorized Person
	  	 Name:
  

Title:

		
	Date: September 1, 2022	  	
		
	Name of Holder: REL Batavia Partnership, L.P.	  	Name of Joint Holder, if applicable:
	 	  	 
	(Please print. Please indicate name and capacity of person signing above)	  	(Please print. Please indicate name and capacity of person signing above)
		
	 Name in which securities are to be registered (if different):
  

Email Address:
  

If there are joint investors, please check one:
  

☐ Joint Tenants with Rights of Survivorship
  

☐ Tenants-in-Common

 
 ☐ Community Property
	  	Notice address (pursuant to Section 5.1 of this Agreement):
		
	 Holder’s EIN: [REDACTED]
  

Business Address-Street: c/o Riverstone Holdings, LLC
	  	 Joint Holder’s EIN:
  

Mailing Address-Street (if different)

	712 Fifth Avenue, 19th Floor	  	 
	New York, NY 10019	  	 
	 City, State, Zip:
  

Attn:
  

Telephone No.:
  

Facsimile No.:
	  	 City, State, Zip:
  

Attn:
  

Telephone No.:
  

Facsimile No.:

 [Signature Page to Subscription and Registration Rights Agreement] 

 EXHIBIT A 

COUNTERPART SIGNATURE PAGE AND JOINDER TO 

SUBSCRIPTION AND REGISTRATION RIGHTS AGREEMENT 

Reference is hereby made to that certain Subscription and Registration Rights Agreement dated as of September 2, 2022, by and among
Tritium DCFC Limited and the other signatories listed as “Holders” therein (as amended, restated or modified from time to time, the “Agreement”). This Counterpart Signature Page and Joinder is delivered pursuant to
Section 1.1(b) or 5.2.4 of the Agreement. 
 The undersigned hereby agrees (i) to become a party to and to be bound by the terms
and conditions of the Agreement as a Holder granted Warrants thereunder and (ii) that the address set forth below the undersigned’s signature shall be the address of the undersigned for purposes of delivering notices under the Agreement to
the undersigned pursuant to Section 5.1 of the Agreement. All capitalized terms not otherwise defined herein shall have the meanings set forth in the Agreement. 

[SIGNATURE PAGE FOLLOWS] 

			
	HOLDER:	  	Number of Warrants:________
		
	Signature of Holder	  	Signature of Joint Holder, if applicable:
		
	 	  	 
		
	By:	  	By:
		
	 Name:
  

Title:
	  	 Name:
  

Title:

		
	Date: ___________, 202__	  	
		
	Name of Holder:	  	Name of Joint Holder, if applicable:
		
	 	  	 
	(Please print. Please indicate name and capacity of person signing above)	  	(Please print. Please indicate name and capacity of person signing above)
		
	 Name in which securities are to be registered (if different):
  

Email Address:
  

If there are joint investors, please check one:
  

☐ Joint Tenants with Rights of Survivorship
  

☐ Tenants-in-Common

 
 ☐ Community Property
	  	Notice address (pursuant to Section 5.1 of this Agreement):
		
	 Holder’s EIN:
  

Business Address-Street:
	  	 Joint Holder’s EIN:
  

Mailing Address-Street (if different)

	 	  	 
	 	  	 
	 City, State, Zip:
  

Attn:
  

Telephone No.:
  

Facsimile No.:
	  	 City, State, Zip:
  

Attn:
  

Telephone No.:
  

Facsimile No.:

 Schedule 6.1.8 

SubsidiariesEX-10.5

 Exhibit 10.5 

Execution Version 

WARRANT AGREEMENT 

TRITIUM DCFC LIMITED 
 THIS
WARRANT AGREEMENT (this “Agreement”), dated as of September 2, 2022, is by and among Tritium DCFC Limited, an Australian public company limited by shares (the “Company” or
“DCFC”), Computershare Inc., a Delaware corporation (“Computershare”), and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, (together with Computershare,
collectively, the “Warrant Agent”). Capitalized terms used in this Agreement and not otherwise defined elsewhere in this Agreement shall have the meanings set forth in Section 10 hereof. 

WHEREAS, in connection with the financing under the Senior Loan Note Subscription Agreement dated as of September 2, 2022 (the
“LNSA”) among the Company and the lenders party thereto (the “Lenders”), the Company is issuing to the Lenders or their affiliates warrants to subscribe for and purchase ordinary shares in the capital
of DCFC (“Ordinary Shares”) (such warrants being referred to as “Warrants”) pursuant to the Subscription and Registration Rights Agreement, dated September 2, 2022 (the “Subscription
Agreement”), by and among the Company and the parties listed under Holder on the signature pages thereto (each such party, together with any person or entity who hereafter becomes a party to the Subscription Agreement pursuant to
Section 1.1 or 5.2 of the Subscription Agreement, a “Holder” and collectively, the “Holders”); and 

WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with
the issuance, registration, transfer, exchange, redemption and exercise of the Warrants and the issuance of Ordinary Shares upon exercise of the Warrants; and 

WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised,
and the respective rights, limitation of rights and immunities of the Company, the Warrant Agent and the Holders; and 
 WHEREAS, all acts
and things have been done and performed which are necessary to make the Warrants, when, if a physical certificate is issued, executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid,
binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement; 
 NOW, THEREFORE, in
consideration of the mutual agreements herein contained, the parties hereto agree as follows: 
 1. Appointment of Warrant Agent. The
Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the express terms and conditions set forth in this
Agreement. 

 2. Warrants. 

2.1. Form of Warrant. Each Warrant shall be issued in registered form only and initially issued in book-entry form. 

2.2. Effect of Countersignature. If a physical certificate is issued, unless and until countersigned in manual, facsimile or other
electronic form by the Warrant Agent pursuant to this Agreement, such physical certificated Warrant shall be invalid and of no effect and may not be exercised by the holder thereof. 

2.3. Registration. 

2.3.1. Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration
of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the respective Holders in such denominations and otherwise in
accordance with instructions delivered to the Warrant Agent by the Company. For the avoidance of doubt, the date of issuance for a given Warrant shall be deemed to be the date specified in the instructions from the Company to the Warrant Agent
instructing the issuance of such Warrant. 
 Physical certificates, if issued, shall be signed by, or bear the facsimile signature of, the
Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Secretary or other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the
capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance. 

2.3.2. Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may
deem and treat the person or entity in whose name such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any
notation of ownership or other writing on any physical certificate made by anyone other than the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by
any notice to the contrary. 
 2.4. Fractional Warrants. The Company shall not issue fractional Warrants. If a holder of Warrants
would be entitled to receive a fractional Warrant, the Company shall round up or down, as applicable, to the nearest whole number the number of Warrants to be issued to such holder. 

3. Terms and Exercise of Warrants. 

3.1. Exercise Price. Each Warrant shall (or if a physical certificate is issued, when countersigned by the Warrant Agent) entitle the
Registered Holder thereof, subject to the provisions of such Warrant, the Subscription Agreement and of this Agreement, to subscribe for and purchase from the Company the number of Ordinary Shares stated therein (the “Warrant
Shares”), at the price of $0.0001 per share (the “Exercise Price”). 

  
 2 

 3.2. Vesting and Expiration of Warrants. 

3.2.1. Vesting Schedule. Subject to Section 3.2.2, the Warrants shall vest and become exercisable by each Registered Holder as
follows: 
  

	 	(a)	 One third of the Warrants will vest and be immediately exercisable upon Financial Close (as defined in the
LNSA); 

  

	 	(b)	 One third of the Warrants will vest and be exercisable on the date that is nine (9) months after the date
of the Financial Close; and 

  

	 	(c)	 One third of the Warrants will vest and be exercisable on the date that is eighteen (18) months after the
date of the Financial Close. 

 3.2.2. Accelerated Vesting. All or any unvested Warrants shall be fully vested and
become immediately exercisable for the maximum number of Ordinary Shares subject to the Warrant if: 
  

	 	(a)	 the closing price per Ordinary Share on the Nasdaq Stock Market over any consecutive fifteen (15)-day period following the date of the Financial Close is equal to or greater than, two times the Initial Share Price; 

  

	 	(b)	 there is a material breach by the Company of this Agreement, the Subscription Agreement or the LNSA;

  

	 	(c)	 there is an Event of Default (as defined in the LNSA); or 

 

	 	(d)	 a third party other than the Registered Holders announces, or the Company announces, an intention to proceed
with a transaction that would reasonably be likely to result in a Change of Control (as defined in the LNSA) or any other transaction having a substantially similar effect. 

3.2.3. Expiration of Unvested Warrants. Any unvested Warrants shall become void, and all rights thereunder and all rights in respect
thereof under this Agreement shall cease upon the earlier to occur of: (i) repayment in full of the Loans (as defined in the LNSA) under the LNSA and the termination of the LNSA and (ii) the termination of the LNSA in connection with non-occurrence of the Financial Close (the “Expiration Date”); provided, however, that notwithstanding the foregoing, any Warrants that have vested on or prior to the Expiration
Date shall continue to be vested and exercisable. 
 3.3. Exercise of Warrants. 

3.3.1. Payment. Subject to the provisions of the Warrant, the Subscription Agreement and this Agreement, a Warrant, when countersigned
by the Warrant Agent if a physical certificate is issued, may be exercised to the extent vested by the Registered Holder thereof by delivering, at the office designated for such purpose, (i) a written notice (an “Exercise
Notice”) of the Registered Holder’s election to subscribe for and purchase (as set forth on the Warrant) the 

  
 3 

 
number of Warrant Shares set forth in such Exercise Notice pursuant to the exercise of a Warrant, properly completed and duly executed by the Registered Holder on the reverse of the warrant
certificate attached as Exhibit A hereto (the “Warrant Certificate”) accompanied by any evidence of authority that may be reasonably required by the Warrant Agent, including but not limited to, a signature guarantee from an
eligible guarantor institution participating in a signature guarantee program approved by the Securities Transfer Association and (ii) the payment in full of the Exercise Price for each Warrant Share as to which the Warrant is exercised and any
and all applicable taxes due in connection with the exercise of the Warrant and the issuance of such Warrant Shares, as follows: 
  

	 	(a)	 in lawful money of the United States, by wire transfer of immediately available funds payable to the
Company’s account at the Warrant Agent; 

  

	 	(b)	 by instructing the Warrant Agent to withhold a number of Warrant Shares then issuable upon exercise of the
Warrant with an aggregate Fair Market Value (as defined below) as of the Exercise Date (as defined below) equal to the aggregate Exercise Price in accordance with the following formula: 

 

			
	 X =
	 	 Y (A-B)

     A

	
	 Where:

		
	X =	 	the net number of Warrant Shares to be issued to the Registered Holder.
		
	Y =	 	the number of Warrant Shares the Registered Holder has elected to subscribe for and purchase under the vested Warrant being exchanged.
		
	A =	 	the Fair Market Value of one Ordinary Share as of the Exercise Date.
		
	B =	 	Exercise Price in effect as of the Exercise Date; or

  

	 	(c)	 any combination of the foregoing. 

 

	 	(d)	 Notwithstanding anything to the contrary herein, beginning on the date that is one (1) year from the
issuance date of the Warrant being exercised, Holders shall only be permitted to exercise the Warrants pursuant to Section 3.3.1(b) above. 

3.3.2. Issuance of Ordinary Shares on Exercise. Within five (5) Business Days of the later of the date of (i) receipt by the
Company of an Exercise Notice (the “Exercise Date”) and (ii) the clearance of the funds in payment of the Exercise Price (if payment is pursuant to subsection 3.3.1(a)) (the “Share Issue
Date”), the Company shall issue to the Registered Holder of such Warrant a book-entry position or certificate, as applicable, for the number of Warrant Shares to which he, she or it is entitled to receive upon exercise of the Warrant
(including any Additional Warrant Shares (as defined below) issuable pursuant to Section 3.3.3), registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been

  
 4 

 
exercised in full, a new book-entry position (or if a physical certificate is issued, a countersigned Warrant Certificate), as applicable, for the number of Warrant Shares as to which such
Warrant shall not have been exercised. No Warrant shall be exercisable and the Company shall not be obligated to issue Warrant Shares upon exercise of a Warrant unless the Warrant Shares issuable upon such Warrant exercise has been registered,
qualified or deemed to be exempt from registration or qualification under the securities laws of the state of residence of the Registered Holder of the Warrants. If, by reason of any exercise of Warrants on a “cashless basis” pursuant to
Section 3.3.1(b), the holder of such Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a Warrant Share, the Company shall, at its election, either (i) pay to the holder an amount in cash (by
wire transfer of immediately available funds) equal to the product of (x) such fraction, multiplied by (y) the Fair Market Value of one Ordinary Share on the Exercise Date or (ii) round up to the nearest whole number the number of
Warrant Shares to be issued to such holder. The Company shall calculate and transmit to the Warrant Agent, and the Warrant Agent shall have no obligation under this Agreement to calculate, such fractional interest. The number of Warrant Shares to be
issued on such exercise of any Warrant will be determined by the Company (with written notice thereof to the applicable Registered Holder and the Warrant Agent) and the Warrant Agent shall have no duty or obligation to investigate or confirm whether
the Company’s determination of the number of Warrant Shares to be issued on such exercise, is accurate or correct. 
 3.3.3.
Guaranteed Value. Within three (3) Business Days of receiving an Exercise Notice, the Company shall calculate the value of the Warrant Shares (prior to any adjustment described in this Section 3.3.3 and without taking into account
any exercise on a “cashless” basis pursuant to Section 3.3.1(b)) issuable to each Registered Holder upon exercise of the Warrant (the “Issue Shares”) as follows (the “Share Valuation”):

 Share Valuation = Issue Shares issuable to such Registered Holder X 5-day VWAP 

Where the “5-day VWAP” means the volume-weighted average price of Ordinary Shares on the
Nasdaq Stock Market for the five (5) trading days immediately preceding the Exercise Date. 
 If the Share Valuation is less than the
Guaranteed Value (as calculated below), the Company shall, on the Share Issue Date, either: 
  

	 	(a)	 pay the difference between the Share Valuation and the Guaranteed Value (the “Value
Difference”) to such Registered Holder or as it may direct, in cash; or 

  

	 	(b)	 adjust the number of Warrant Shares issuable on the Share Issue Date to include additional Ordinary Shares to
such Registered Holder (“Additional Warrant Shares”), where such number of Additional Warrant Shares will be calculated as the Value Difference, divided by the 5-day VWAP (rounded up to
the nearest whole Ordinary Share). 

 The Company may elect to pay the Value Difference in cash or issue Additional Warrant Shares as
provided in Section 3.3.2 in its sole discretion, and in such circumstances the Registered Holder shall be deemed to have subscribed for such number of Additional Warrant Shares so calculated, except that to the extent the issue of Additional
Warrant Shares would to the 

  
 5 

 
Company’s actual knowledge cause a Registered Holder to hold 10% or more of the issued Ordinary Shares of the Company or a Registered Holder and its affiliates (the “Warrant
Holder Affiliated Group”) to hold collectively 20% or more of the issued Ordinary Shares in the Company, the Company shall pay cash for any Additional Warrant Shares that would cause the Registered Holder or Warrant Holder Affiliated
Group to exceed the 10% or 20% threshold, respectively, in lieu of issuing such Additional Warrant Shares. 
 The “Guaranteed
Value” shall be calculated by multiplying the Issue Shares by the Initial Share Price and by the percentage in the following table that corresponds to the last date before the relevant Exercise Date: 

 

					
	 To and Including
	  	Percentage	 
	 24 Months from Financial Close
	  	 	67	% 
	 30 Months from Financial Close
	  	 	80	% 
	 Thereafter
	  	 	100	% 

 For the avoidance of doubt, if the Share Valuation equals or exceeds the Guaranteed Value, there will be no adjustment to the
number of Warrant Shares issued or cash paid pursuant to this Section 3.3.3. 
 3.3.4. Valid Issuance; Listing. All Ordinary
Shares issued upon the proper exercise of a Warrant in conformity with this Agreement and duly authorized by all necessary corporate action on the part of the Company shall be validly issued, fully paid and shall not be subject to any call for
payment of any further capital (subject to full payment therefor in accordance with the terms of this Agreement). The Company shall cause the Ordinary Shares issued upon the proper exercise of a Warrant to be listed on the Nasdaq Stock Market or
such other U.S. national securities exchange on which the Ordinary Shares are then listed. 
 3.3.5. Date of Issuance. Each person
or entity in whose name any book-entry position or certificate, as applicable, for Warrant Shares and any Additional Warrant Shares is issued shall for all purposes be deemed to have become the holder of record of such Warrant Shares and any
Additional Warrant Shares on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the Exercise Price was made in accordance with Section 3.3.1, irrespective of the date of delivery of
such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person or entity shall
be deemed to have become the holder of such Warrant Shares and any Additional Warrant Shares at the close of business on the next succeeding date on which the share transfer books or book-entry system are open. 

3.3.6. Maximum Percentage. The Warrant Agent shall not effect the exercise of the holder’s Warrant, and such holder shall not
have the right to exercise such Warrant, to the extent that after giving effect to such exercise, (a) such holder or (b) such holder (together with such holder’s affiliates), to the Warrant Agent’s actual knowledge, would
beneficially own 10% or more (the “Holder Maximum Percentage”) or 20% or more (the “Holder Group Maximum  

  
 6 

 
Percentage”), respectively, of the Ordinary Shares issued immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of
Ordinary Shares beneficially owned by such person or its affiliates shall include the number of Ordinary Shares issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude Ordinary
Shares that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other
securities of the Company beneficially owned by such person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the
limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”). For purposes of the Warrant, in determining the number of issued Ordinary Shares, the holder may rely on the number of issued Ordinary Shares as reflected in (1) the Company’s most recent Annual
Report on Form 20-F, Current Report on Form 6-K or other public filing with the Securities and Exchange Commission (the “Commission”) as the case
may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or Computershare Inc. and Computershare Trust Company, N.A., jointly, in their capacity as the transfer agent for the Ordinary Shares (the
“Transfer Agent”) setting forth the number of Ordinary Shares issued. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and
in writing to such holder the number of Ordinary Shares then issued. In any case, the number of issued Ordinary Shares shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its
affiliates since the date as of which such number of issued Ordinary Shares was reported. 
 3.3.7. Notwithstanding any other term of this
Agreement, such holder shall not have the right to exercise a Warrant (and the existence of the right to exercise is conditional upon obtaining, and shall not become binding until the applicable holder obtains, a
no-objection notification required to be obtained under the Foreign Acquisitions and Takeovers Act 2015 (Cth)), to the extent that the exercise of such Warrant would result in: 

 

	 	(a)	 a person acquiring a Relevant Interest in the voting shares in the Company in breach of section 606(1) of the
Australian Corporations Act 2001 (Cth) (“Corporations Act”) (or any equivalent provision); or 

  

	 	(b)	 a “foreign person” or a “foreign government investor” (each within the meaning given to
that term in the Australian Foreign Acquisitions and Takeovers Act 2015 (Cth)) acquiring Ordinary Shares in breach of the Foreign Acquisitions and Takeovers Act 2015 (Cth). 

3.3.8. Cost Basis Information. 
  

	 	(a)	 In the event of a cash exercise pursuant to Section 3.3.1(a) hereof, the Company hereby instructs the
Warrant Agent to record cost basis for the newly issued Ordinary Shares in a manner to be subsequently communicated by the Company in writing to the Warrant Agent. 

  
 7 

	 	(b)	 In the event of a cashless exercise pursuant to Section 3.3.1(b) hereof, the Company shall provide cost
basis for the Ordinary Shares issued pursuant to a cashless exercise at the time the Company confirms the number of Warrant Shares issuable in connection with the cashless exercise to the Warrant Agent pursuant to Section 3.3.1 hereof.

 4. Adjustments to Number of Warrant Shares. In order to prevent dilution of the subscription and purchase rights
granted under this Agreement, the number of Warrant Shares issuable upon exercise of a Warrant shall be subject to adjustment from time to time as provided in this Section 4 (in each case, after taking into consideration any prior adjustments
pursuant to this Section 4). 
 4.1. Adjustment to Number of Warrant Shares Upon Issuance of Ordinary Shares. Except as provided
in Section 4.2 and except in the case of an event described in either Section 4.4 or Section 4.5, if the Company shall, at any time or from time to time after the date of this Agreement (the “Original Issue
Date”), issue, or in accordance with Section 4.3 is deemed to have issued, any Ordinary Shares without consideration or for consideration per share less than Initial Share Price (as such amount is proportionately adjusted for stock
splits, reverse stock splits, stock combinations, stock dividends and other distributions and recapitalizations affecting the Ordinary Shares after the Original Issue Date, the “Original Price”), then immediately upon such
issuance (or deemed issuance), the number of Warrant Shares issuable upon exercise of any then-unexercised portion of this Warrant immediately prior to any such issuance (or deemed issuance) shall be increased to a number of Warrant Shares as is
computed using the following formula: 
  

			
	Y =	 	 A X B 
 (C + D)

	
	 Where:

		
	Y =	 	the increased aggregate number of Warrant Shares.
		
	A =	 	the number of Warrant Shares issuable upon exercise of any then-unexercised portion of this Warrant immediately prior to such issuance (or deemed issuance).
		
	B =	 	the number of Ordinary Shares actually issued immediately after such issuance (or deemed issuance).
		
	C =	 	the number of Ordinary Shares actually issued immediately prior to such issuance (or deemed issuance).
		
	D =	 	the aggregate number of Ordinary Shares which the aggregate amount of consideration, if any, received by the Company upon such issuance (or deemed issuance) would be able to subscribe for and purchase at the Original
Price.

  
 8 

 4.2. Exceptions to Adjustment Upon Issuance of Ordinary Shares. Anything herein to
the contrary notwithstanding, there shall be no adjustment to the number of Warrant Shares issuable upon exercise of this Warrant with respect to any Excluded Issuance. 

4.3. Effect of Certain Events on Adjustment to Number of Warrant Shares. For purposes of determining the adjusted number of Warrant
Shares under Section 4.1 hereof, the following shall be applicable: 
 4.3.1. Issuance of Options. If the Company shall,
at any time or from time to time after the Original Issue Date, in any manner grant (whether directly or by assumption in a merger or otherwise) any Options, whether or not such Options or the right to convert or exchange any Convertible Securities
issuable upon the exercise of such Options are immediately exercisable, and the price per share (determined as provided in this Section 4.3.1 and in Section 4.3.5) for which Ordinary Shares are issuable upon the exercise of such
Options or upon the conversion or exchange of Convertible Securities issuable upon the exercise of such Options is less than the Original Price in effect immediately prior to the time of the granting of such Options, then the total maximum number of
Ordinary Shares issuable upon the exercise of such Options or upon conversion or exchange of the total maximum amount of Convertible Securities issuable upon the exercise of such Options shall be deemed to have been issued as of the date of granting
of such Options (and thereafter shall be deemed to be issued for purposes of adjusting the number of Warrant Shares under Section 4.1), at a price per share equal to the quotient obtained by dividing (A) the sum (which sum shall
constitute the applicable consideration received for purposes of Section 4.1) of (x) the total amount, if any, received or receivable by the Company as consideration for the granting of all such Options, plus (y) the minimum aggregate
amount of additional consideration payable to the Company upon the exercise of all such Options, plus (z), in the case of such Options which relate to Convertible Securities, the minimum aggregate amount of additional consideration, if any, payable
to the Company upon the issuance of all such Convertible Securities and the conversion or exchange of all such Convertible Securities, by (B) the total maximum number of Ordinary Shares issuable upon the exercise of all such Options or upon the
conversion or exchange of all Convertible Securities issuable upon the exercise of all such Options. Except as otherwise provided in Section 4.3.3, no further adjustment of the number of Warrant Shares shall be made upon the actual
issuance of Ordinary Shares or of Convertible Securities upon exercise of such Options or upon the actual issuance of Ordinary Shares upon conversion or exchange of Convertible Securities issuable upon exercise of such Options. 

4.3.2. Issuance of Convertible Securities. If the Company shall, at any time or from time to time after the Original Issue Date, in
any manner grant (whether directly or by assumption in a merger or otherwise) any Convertible Securities, whether or not the right to convert or exchange any such Convertible Securities is immediately exercisable, and the price per share (determined
as provided in this Section 4.3.2 and in Section 4.3.5) for which Ordinary Shares are issuable upon the conversion or exchange of such Convertible Securities is less than the Original Price in effect immediately prior to the time of
the granting of such Convertible Securities, then the total maximum number of Ordinary Shares issuable upon conversion or exchange of the 

  
 9 

 
total maximum amount of such Convertible Securities shall be deemed to have been issued as of the date of granting of such Convertible Securities (and thereafter shall be deemed to be issued for
purposes of adjusting the number of Warrant Shares pursuant to Section 4.1), at a price per share equal to the quotient obtained by dividing (A) the sum (which sum shall constitute the applicable consideration received for purposes
of Section 4.1) of (x) the total amount, if any, received or receivable by the Company as consideration for the granting of such Convertible Securities, plus (y) the minimum aggregate amount of additional consideration, if any,
payable to the Company upon the conversion or exchange of all such Convertible Securities, by (B) the total maximum number of Ordinary Shares issuable upon the conversion or exchange of all such Convertible Securities. Except as otherwise
provided in Section 4.3.3, no further adjustment of the number of Warrant Shares shall be made upon the actual issuance of Ordinary Shares upon conversion or exchange of such Convertible Securities or by reason of the issue of
Convertible Securities upon exercise of any Options to subscribe for and purchase any such Convertible Securities for which adjustments of the number of Warrant Shares have been made pursuant to the other provisions of this Section 4.3.

 4.3.3. Change in Terms of Options or Convertible Securities. Upon any change in any of (A) the total amount received or
receivable by the Company as consideration for the granting of any Options or Convertible Securities referred to in Section 4.3.1 or Section 4.3.2 hereof, (B) the minimum aggregate amount of additional consideration, if
any, payable to the Company upon the exercise of any Options or upon the issuance, conversion or exchange of any Convertible Securities referred to in Section 4.3.1 or Section 4.3.2 hereof, (C) the rate at which
Convertible Securities referred to in Section 4.3.1 or Section 4.3.2 hereof are convertible into or exchangeable for Ordinary Shares, or (D) the maximum number of Ordinary Shares issuable in connection with any Options
referred to in Section 4.3.1 hereof or any Convertible Securities referred to in Section 4.3.2 hereof (in each case, other than in connection with an Excluded Issuance), then (whether or not the original issuance of such
Options or Convertible Securities resulted in an adjustment to the number of Warrant Shares pursuant to this Section 4) the number of Warrant Shares issuable upon exercise of this Warrant at the time of such change shall be adjusted or
readjusted, as applicable, to the number of Warrant Shares which would have been in effect at such time pursuant to the provisions of this Section 4 had such Options or Convertible Securities which are still issued at the time of such change
provided for such changed consideration, conversion rate, or maximum number of shares, as the case may be, at the time initially granted or issued, but only if as a result of such adjustment or readjustment, the number of Warrant Shares issuable
upon exercise of this Warrant is increased. 
 4.3.4. Treatment of Expired or Terminated Options or Convertible Securities. Upon the
expiration or termination of any unexercised Option (or portion thereof) or any unconverted or unexchanged Convertible Security (or portion thereof) for which any adjustment (either upon its original issuance or upon a revision of its terms) was
made pursuant to this Section 4 (including without limitation upon the redemption or subscribe for consideration of all or any portion of such Option or Convertible Security by the Company), the number of Warrant Shares then issuable upon
exercise of this Warrant shall forthwith be changed pursuant to the provisions of this Section 4 to the number of Warrant Shares which would have been in effect at the time of such expiration or termination had such unexercised Option (or
portion thereof) or unconverted or unexchanged Convertible Security (or portion thereof), to the extent still issued immediately prior to such expiration or termination, never been issued. 

  
 10 

 4.3.5. Calculation of Consideration Received. If the Company shall, at any time or
from time to time after the Original Issue Date, issue, or is deemed to have issued in accordance with Section 4.3, any Ordinary Shares, Options, or Convertible Securities: (A) for cash, the consideration received therefor shall be
deemed to be the net amount received by the Company therefor; (B) for consideration other than cash, the amount of the consideration other than cash received by the Company shall be the fair value of such consideration, except where such
consideration consists of marketable securities, in which case the amount of consideration received by the Company shall be the market price (as reflected on any securities exchange, quotation system or association, or similar pricing system
covering such security) for such securities as of the end of business on the date of receipt of such securities; (C) for no specifically allocated consideration in connection with an issuance of other securities of the Company, together
comprising one integrated transaction, the amount of the consideration therefor shall be deemed to have been issued without consideration; or (D) to the owners of the non-surviving entity in connection
with any merger in which the Company is the surviving corporation, the amount of consideration therefor shall be deemed to be the fair value of such portion of the net assets and business of the non-surviving
entity as is attributable to such Ordinary Shares, Options, or Convertible Securities, as the case may be, issued to such owners. The net amount of any cash consideration and the fair value of any consideration other than cash or marketable
securities shall be determined in good faith jointly by the Board of Directors of the Company (the “Board”) and the Holder; provided, that if the Board and the Holder are unable to agree on the net amount of any cash
consideration or the fair value of any consideration other than cash or marketable securities within a reasonable period of time, such net amount of cash or fair value, as applicable, shall be determined by a firm of independent public accountants,
investment banking or other appraisal firm of recognized national standing engaged by the Company. The determination of such firm shall be final and conclusive, and the fees and expenses of such valuation firm shall be borne by the Company. 

4.3.6. Record Date. For purposes of any adjustment to the number of Warrant Shares in accordance with this Section 4, in case the
Company shall take a record of the holders of its Ordinary Shares for the purpose of entitling them (A) to receive a dividend or other distribution payable in Ordinary Shares, Options, or Convertible Securities or (B) to subscribe for or
purchase Ordinary Shares, Options, or Convertible Securities, then such record date shall be deemed to be the date of the issue of the Ordinary Shares deemed to have been issued or sold upon the declaration of such dividend or the making of such
other distribution or the date of the granting of such right of subscription or purchase, as the case may be; provided, that if before the distribution to its holders of Ordinary Shares the Company legally abandons its plan to pay or deliver
such dividend, distribution, subscription, or purchase rights, then thereafter no adjustment shall be required by the taking of such record and any such adjustment previously made in respect thereof shall be rescinded and annulled. 

  
 11 

 4.3.7. Other Dividends and Distributions. Subject to the provisions of this
Section 4.3, if the Company shall, at any time or from time to time after the Original Issue Date, make or declare, or fix a record date for the determination of holders of Ordinary Shares entitled to receive, a dividend or any other
distribution payable in securities of the Company (other than a dividend or distribution of Ordinary Shares, Options, or Convertible Securities in respect of issued Ordinary Shares), cash, or other property, then, and in each such event, provision
shall be made so that the Holder shall receive upon exercise of the Warrant, in addition to the number of Warrant Shares receivable thereupon, the kind and amount of securities of the Company, cash, or other property which the Holder would have been
entitled to receive had the Warrant been exercised in full into Warrant Shares on the date of such event and had the Holder thereafter, during the period from the date of such event to and including the Exercise Date, retained such securities, cash,
or other property receivable by them as aforesaid during such period, giving application to all adjustments called for during such period under this Section 4 with respect to the rights of the Holder; provided, that no such provision
shall be made if the Holder receives, simultaneously with the distribution to the holders of Ordinary Shares, a dividend or other distribution of such securities, cash, or other property in an amount equal to the amount of such securities, cash, or
other property as the Holder would have received if the Warrant had been exercised in full into Warrant Shares on the date of such event. 

4.4. Adjustment to Number of Warrant Shares Upon Dividend, Subdivision or Combination of Ordinary Shares. If the Company shall, at any
time or from time to time after the Original Issue Date, (i) pay a dividend or make any other distribution upon the Ordinary Shares or any other capital stock of the Company payable in Ordinary Shares or in Options or Convertible Securities, or
(ii) subdivide (by any stock split, recapitalization, or otherwise) its issued Ordinary Shares into a greater number of shares, the number of Warrant Shares issuable upon exercise of this Warrant immediately prior to any such dividend,
distribution, or subdivision shall be proportionately increased. If the Company at any time combines (by combination, reverse stock split, or otherwise) its issued Ordinary Shares into a smaller number of shares, the number of Warrant Shares
issuable upon exercise of this Warrant immediately prior to such combination shall be proportionately decreased. Any adjustment under this Section 4.4 shall become effective at the close of business on the date the dividend, subdivision, or
combination becomes effective. 
 4.5. Adjustment to Number of Warrant Shares Upon Reorganization, Reclassification, Consolidation, or
Merger. In the event of any (i) capital reorganization of the Company, (ii) reclassification of the stock of the Company (other than as a result of a stock dividend or subdivision, split-up, or
combination of shares), (iii) consolidation or merger of the Company with or into another Person, (iv) sale of all or substantially all of the Company’s assets to another Person or (v) other similar transaction (other than any such
transaction covered by Section 4.4), in each case which entitles the holders of Ordinary Shares to receive (either directly or upon subsequent liquidation) stock, securities, or assets with respect to or in exchange for Ordinary Shares, each
Warrant shall, immediately after such reorganization, reclassification, consolidation, merger, sale, or similar transaction, remain issued and shall thereafter, in lieu of or in addition to (as the case may be) the number of Warrant Shares then
exercisable under this Warrant, be exercisable for the kind and number of shares of stock or other securities or assets of the Company or of the successor Person resulting from such transaction to which the Holder would have been entitled upon such
reorganization, reclassification, consolidation, merger, sale, or similar transaction if the Holder had exercised this Warrant in full immediately prior to the time of such reorganization, reclassification, consolidation, merger, sale, or similar
transaction and acquired the applicable number of Warrant Shares then issuable hereunder as a result of such 

  
 12 

 
exercise (without taking into account any limitations or restrictions on the exercisability of this Warrant); and, in such case, appropriate adjustment (in form and substance satisfactory to the
Holder) shall be made with respect to the Holder’s rights under this Warrant to insure that the provisions of this Section 4 hereof shall thereafter be applicable, as nearly as possible, to this Warrant in relation to any shares of stock,
securities, or assets thereafter acquirable upon exercise of this Warrant. The provisions of this Section 4.5 shall similarly apply to successive reorganizations, reclassifications, consolidations, mergers, sales, or similar transactions. The
Company shall not effect any such reorganization, reclassification, consolidation, merger, sale, or similar transaction unless, prior to the consummation thereof, the successor Person (if other than the Company) resulting from such reorganization,
reclassification, consolidation, merger, sale, or similar transaction, shall assume, by written instrument substantially similar in form and substance to this Warrant and satisfactory to the Holder, the obligation to deliver to the Holder such
shares of stock, securities, or assets which, in accordance with the foregoing provisions, such Holder shall be entitled to receive upon exercise of this Warrant. Notwithstanding anything to the contrary contained herein, with respect to any
corporate event or other transaction contemplated by the provisions of this Section 4.5, the Holder shall have the right to elect prior to the consummation of such event or transaction, to give effect to the exercise rights contained in
Section 3 instead of giving effect to the provisions contained in this Section 4.5 with respect to this Warrant. 
 4.6. Other
Events. In case any event shall occur affecting the Company as to which none of the provisions of the preceding subsections of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in
order to (i) avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or
other appraisal firm of recognized national standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and purpose of this Section 4 and, if they
determine that an adjustment is necessary, the terms of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion; provided, that no such adjustment
pursuant to this Section 4.6 shall decrease the number of Warrant Shares issuable as otherwise determined pursuant to this Section 4. 

4.7. Notices of Changes in Warrant. Upon every adjustment of the number of Warrant Shares issuable upon exercise of a Warrant, the
Company shall give written notice thereof to the Warrant Agent, which notice shall state the increase or decrease, if any, in the number of Warrant Shares which may be subscribed for and purchased upon the exercise of a Warrant, setting forth in
reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3, 4.4, 4.5 or 4.6, the Company shall give written notice of the occurrence of such
event to each holder of a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or
validity of such event. The Warrant Agent shall have no obligation under any Section of this Agreement to determine whether such adjustment event has occurred or to calculate any of the adjustments set forth herein. The Warrant Agent shall be fully
protected in relying on any such notice and on any adjustment therein contained and shall have no duty or liability with respect to, and shall not be deemed to have knowledge of, such adjustment unless and until it shall have received such notice.

  
 13 

 4.8. No Fractional Shares. Notwithstanding any provision contained in this Agreement
to the contrary, the Company shall not issue fractional Ordinary Shares upon the exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled, upon the exercise of such
Warrant, to receive a fractional interest in an Ordinary Share, the Company shall, upon such exercise, at its election either (i) pay to the holder an amount in cash (by wire transfer of immediately available funds) equal to the product of
(x) such fraction, multiplied by (y) the Fair Market Value of one Ordinary Share on the Exercise Date or (ii) round up to the nearest whole number the number of Ordinary Shares to be issued to such holder. 

4.9. Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants
issued after such adjustment may state the same Exercise Price and the same number of Ordinary Shares as is stated in the Warrants initially issued pursuant to the Subscription Agreement; provided, however, that the Company may at any
time in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued (or if a physical certificate is issued, countersigned),
whether in exchange or substitution for an issued Warrant or otherwise, may be in the form as so changed. 
 5. Transfer and Exchange of
Warrants. 
 5.1. Restrictions on Transfer. Neither this Agreement nor any Warrant may be transferred or assigned except
(i) with the written consent of the Company (which may not be unreasonably withheld or delayed) or (ii) that the Holder may assign any Warrant and its rights and obligations under this Agreement to one or more of its affiliates without the
consent of the Company; provided that such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement. 

5.2. Registration of Transfer. To the extent the transfer of a Warrant is permitted pursuant to Section 5.1, the Warrant Agent
shall register the transfer, from time to time, of any issued Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with any evidence of authority that may be reasonably required by the Warrant Agent,
including but not limited to, a signature guarantee from an eligible guarantor institution participating in a signature guarantee program approved by the Securities Transfer Association and accompanied by appropriate instructions for transfer. Upon
any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent to the Company from
time to time upon request. 
 5.3. Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together
with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number
of Warrants; 

  
 14 

 
provided, however, that in the event that a Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in
exchange thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend. 

5.4. Transfers of Fractions of Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange of
Warrants which would require the issuance of a Warrant Certificate or book-entry position for a fraction of a warrant. 
 5.5. Service
Charges. No service charge shall be made for any exchange or registration of transfer of Warrants. 
 5.6. Warrant Execution and
Countersignature. The Warrant Agent is hereby authorized, if a physical certificate is issued, to countersign, and to deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this
Section 5, and the Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose. 

6. Redemption. 
 6.1.
Redemption of Warrants for Cash. The Company shall have the right to redeem all or any portion of the unvested issued Warrants at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in
Section 6.2 below, at a redemption price per Warrant equal to the Initial Share Price (the “Redemption Price”); provided, however, that any such redemption of Warrants hereunder shall be for a minimum
aggregate Redemption Price of one million U.S. dollars ($1,000,000) and shall be effected on a pro rata basis among all issued Warrants. The Company may only exercise the redemption right under this Section 6.1 three (3) times. 

6.2. Date Fixed for, and Notice of, Redemption; Redemption Price. In the event that the Company elects to redeem the Warrants pursuant
to Section 6.1 hereof, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be transmitted and/or mailed (by first class mail, postage prepaid), by the Company not less than
thirty (30) days prior to the Redemption Date to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice transmitted or mailed in the manner herein provided shall
be conclusively presumed to have been duly given whether or not the Registered Holder received such notice. 
 7. Other Provisions
Relating to Rights of Holders of Warrants. 
 7.1. No Rights as Stockholder. A Warrant does not entitle the Registered Holder
thereof to any of the rights of stockholders of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as a stockholder in respect
of the meetings of stockholders or the election of directors of the Company or any other matter. 

  
 15 

 7.2. Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant Certificate is
lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may, absent notice to Warrant Agent that such Warrant Certificate has been acquired by a bona fide purchaser, on such terms as to indemnity or otherwise as they may in their
discretion impose (which terms shall in all cases include posting of a lost security bond by or on behalf of the Registered Holder holding the Warrant Agent and the Company harmless, and in the case of a mutilated Warrant Certificate, include the
surrender thereof), issue a new Warrant Certificate of like denomination, tenor and date as the Warrant Certificate so lost, stolen, mutilated or destroyed. Any Warrant represented by such new Warrant Certificate shall constitute a substitute
contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant Certificate shall be at any time enforceable by anyone. 

7.3. Registration of Warrants and Ordinary Shares. The Company shall provide the holders of the Warrants with certain registration
rights pursuant to that certain Subscription Agreement entered into in connection with the issuance of the Warrants. 
 8. Concerning the
Warrant Agent and Other Matters. 
 8.1. Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges
that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of Ordinary Shares upon the exercise of the Warrants, but neither the Company nor the Warrant Agent shall be obligated to pay any transfer taxes in
respect of the Warrants or such Ordinary Shares, save as expressly stated in this Section 8.1. The Warrant Agent shall not register any transfer or issue or deliver any Warrant Certificate(s) or Warrant Shares unless or until the persons
requesting the registration or issuance shall have paid to the Warrant Agent for the account of the Company the amount of such tax, if any, or shall have established to the reasonable satisfaction of the Company and the Warrant Agent that such tax,
if any, has been paid. 
 8.2. Resignation, Consolidation, or Merger of Warrant Agent. 

8.2.1. Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties
and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the
Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified in writing of such resignation or
incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with such notice, submit his, her or its Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York for the
County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized and existing under the
laws of the United States of America, or any state thereof, in good standing and having its principal office in the United States of America, and authorized under such laws to exercise corporate trust or stock transfer powers and subject to
supervision or examination by federal or state authority. After 

  
 16 

 
appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if
originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all
instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations. 

8.2.2. Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice
thereof to the predecessor Warrant Agent and the Transfer Agent not later than the effective date of any such appointment. 
 8.2.3.
Merger or Consolidation of Warrant Agent. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be
the successor Warrant Agent under this Agreement without any further act. 
 8.3. Fees and Expenses of Warrant Agent. 

8.3.1. Remuneration. The Company agrees to pay to the Warrant Agent reasonable compensation for all services rendered by it hereunder
in accordance with a fee schedule to be mutually agreed upon and, from time to time, on demand of the Warrant Agent, its reasonable and documented expenses and counsel fees and disbursements and other disbursements incurred in the preparation,
negotiation, execution, administration, delivery and amendment of this Agreement and the exercise and performance of its duties hereunder. 

8.3.2. Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed,
acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement. 

8.4. Liability of Warrant Agent. 

8.4.1. Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it
necessary or desirable that any fact or matter be proved or established by the Company prior to taking, suffering or omitting to take any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically
prescribed) may be deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, Secretary or Chairman of the Board and delivered to the Warrant Agent. The Warrant Agent may rely upon
such statement and shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it under this Agreement in reliance upon such certificate. 

  
 17 

 8.4.2. Indemnity. The Warrant Agent shall be liable hereunder only for its own gross
negligence, willful misconduct or bad faith (in each case, as determined by a final, non-appealable judgment of a court of competent jurisdiction). The Company agrees to indemnify the Warrant Agent and save it harmless against any and all
liabilities loss, damage, judgment, fine, penalty, claim, demand, settlement, reasonable cost or expense that is paid, incurred or to which it becomes subject, including judgments, costs and reasonable counsel fees, for anything done or omitted by
the Warrant Agent for any action taken, suffered or omitted to be taken by the Warrant Agent in connection with the execution, acceptance, administration, exercise and performance of its duties under this Agreement, including the reasonable costs
and expenses of defending against any claim of liability arising therefrom, directly or indirectly, or of enforcing its rights under this Agreement, except (i) as a result of the Warrant Agent’s gross negligence, willful misconduct or bad
faith (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction); or (ii) any tax imposed on or calculated as a result of the net income received or receivable
by the Warrant Agent under applicable law. Notwithstanding anything in this Agreement to the contrary, in no event shall the Warrant Agent be liable for special, punitive, incidental, indirect or consequential loss or damage of any kind whatsoever,
even if the Warrant Agent has been advised of the likelihood of such loss or damage and regardless of the form of the action. Notwithstanding anything to the contrary herein, any liability, other than liability arising out of or attributable to the
Warrant Agent’s gross negligence, willful misconduct or bad faith (in each case as determined by a final, non-appealable judgment of a court of competent jurisdiction) of the Warrant Agent under this
Agreement shall be limited to the amount of fees (but not including any reimbursed costs) paid by the Company to the Warrant Agent during the twelve (12) months immediately preceding the event for which recovery from the Warrant Agent is being
sought. 
 8.4.3. Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with
respect to the validity or execution of any Warrant (except if a physical certificate is issued, its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant or condition contained in this
Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the
existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization of any Ordinary Shares to be issued pursuant to this Agreement or any Warrant or as
to whether any Ordinary Shares shall, when issued, be valid and fully paid and not subject to any call for the payment of further capital. 

8.5. Other Rights of the Warrant Agent. 

8.5.1. Counsel. The Warrant Agent may consult with legal counsel (who may be legal counsel for the Company), and the opinion or advice
of such counsel shall be full and complete authorization and protection to the Warrant Agent as to any action taken or omitted by it in accordance with such opinion or advice. 

8.5.2. Reliance on Attorneys and Agents. The Warrant Agent may execute and exercise any of the rights or powers hereby vested in it or
perform any duty hereunder either itself or by or through its attorney or agents, and the Warrant Agent shall not be answerable or accountable for any act, default, neglect or misconduct of any such attorney or agents or for any loss to the Company
resulting from any such act, default, neglect or misconduct, absent gross negligence, bad faith or willful misconduct (each as determined by a final non-appealable judgment of a court of competent
jurisdiction) in the selection and continued employment thereof. 

  
 18 

 8.5.3. Company Instructions. The Warrant Agent may rely on and shall be held
harmless and protected and shall incur no liability for or in respect of any action taken, suffered or omitted to be taken by it in reliance upon any certificate, statement, instrument, opinion, notice, letter, facsimile transmission, or other
document, or any security delivered to it, and believed by it to be genuine and to have been made or signed by the proper party or parties, or upon any written instructions or statements from the Company with respect to any matter relating to its
acting as Warrant Agent hereunder. 
 8.5.4. No Risk of Own Funds. The Warrant Agent shall not be obligated to expend or risk its
own funds or to take any action that it believes would expose or subject it to expense or liability or to a risk of incurring expense or liability, unless it has been furnished with assurances of repayment or indemnity satisfactory to it. 

8.5.5. Opinion of Counsel. The Company shall provide an opinion of counsel reasonably satisfactory to the Warrant Agent prior to the
effective date of this Agreement which shall state that all Warrants or Ordinary Shares, as applicable, are: (1) registered under the Securities Act of 1933, as amended (the “Securities Act”), or are exempt from such
registration, and all appropriate state securities law filings have been made with respect to the Warrants; and (2) validly issued, fully paid and non-assessable. 

8.5.6. Bank Accounts. All funds received by Computershare under this Agreement that are to be distributed or applied by Computershare
in the performance of services hereunder (the “Funds”) shall be held by Computershare as agent for the Company and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for the Company
and shall distribute or apply, as applicable, such Funds in accordance with the terms and conditions herein. Computershare shall have no responsibility or liability for any diminution of the Funds that may result from any deposit made by
Computershare in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party. Computershare may from time to time receive interest, dividends or other earnings in connection
with such deposits. Computershare shall not be obligated to pay such interest, dividends or earnings to the Company, any holder or any other party. 

8.6. Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same
upon the express terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent
for the subscription and purchase of Ordinary Shares through the exercise of the Warrants. 
 8.7. Survival. The obligations of the
Company under this Section 8 shall survive the termination of this Agreement, the resignation, replacement or removal of the Warrant Agent and the exercise, termination and expiration of the Warrant. 

  
 19 

 8.8. Delivery of Exercise Price. The Warrant Agent shall forward funds received for
warrant exercises in a given month by the fifth (5th) Business Day of the following month by wire transfer to an account designated by the Company. 

8.9. Confidentiality. The Warrant Agent and the Company agree that all books, records, information and data pertaining to the business
of the other party, including inter alia, personal, non-public warrant holder information, which are exchanged or received pursuant to the negotiation or the carrying out of this Agreement including the
fees for services shall remain confidential, and shall not be voluntarily disclosed to any other person, except as may be required by law, including, without limitation, pursuant to (i) subpoenas from state or federal government authorities
(e.g., in divorce and criminal actions) or (ii) securities law disclosure rule or disclosure rules of the Commission or any stock exchange. However, each party hereto may disclose relevant aspects of the other party’s confidential
information to its officers, affiliates, employees and advisors to the extent reasonably necessary to perform its duties and obligations hereunder. 

9. Miscellaneous Provisions. 

9.1. Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall
bind and inure to the benefit of their respective successors and assigns. 
 9.2. Notices. Any notice, statement or demand authorized
by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service
within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows: 

Tritium DCFC Limited 
 48 Miller Street 

Murarrie, QLD 4172 
 Australia 

Attention: Company Secretary 
 Email: legal@tritium.com.au 

With a copy to: 
 Latham & Watkins LLP 

330 North Wabash Avenue, Suite 2800 
 Chicago, Illinois 60611 

Attention: Christopher Lueking 
 Email:
Christopher.Lueking@lw.com 
 and 

  
 20 

 Corrs Chambers Westgarth 

Level 42, 111 Eagle Street 
 Brisbane, QLD 4000 

Australia 
 Attention: Alex Feros 

Email: Alexandra.Feros@corrs.com.au 
 Any notice,
statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be in writing and sufficiently given when so delivered if by hand or overnight delivery or if sent
by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows: 

Computershare Inc. 
 Computershare Trust Company, N.A. 

150 Royall Street 
 Canton, MA 02021 

Attn: Client Services 
 9.3. Applicable
Law. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the
application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement, including under the Securities Act, shall be brought and
enforced in the courts of the State of New York or the United States District Court for the Southern District of New York (and the appellate courts thereof), and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive;
provided, however, that the foregoing shall not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole
and exclusive forum. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the Company and the Warrant Agent may mutually agree to a jurisdiction
other than New York for any litigation directly between the Company and the Warrant Agent arising out of or relating to this Agreement. 

9.4. Persons Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person or
entity other than the parties hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions,
stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants. 

  
 21 

 9.5. Examination of the Warrant Agreement. A copy of this Agreement shall be
available at all reasonable times at the office of the Warrant Agent designated for such purpose, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to submit such holder’s Warrant for
inspection by the Warrant Agent. 
 9.6. Counterparts. This Agreement may be executed in any number of original or facsimile
counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signature to this Agreement transmitted electronically shall have
the same authority, effect, and enforceability as an original signature. 
 9.7. Effect of Headings. The section headings herein are
for convenience only and are not part of this Agreement and shall not affect the interpretation thereof. 
 9.8. Amendments. This
Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained herein or adding or changing any other
provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders. All other modifications or
amendments shall require the vote or written consent of the Registered Holders holding 66-2/3% of the issued Warrants. No amendment to this Agreement shall be effective unless duly executed by the Warrant
Agent. As a condition precedent to the execution by the Warrant Agent of an amendment to this Agreement, the Company shall deliver a certificate from an authorized signatory which states that the proposed amendment is in compliance with the terms of
this Section 9.8. Notwithstanding anything in this Agreement to the contrary, the Warrant Agent may, but shall not be obligated to, enter into any supplement or amendment that adversely affects the Warrant Agent’s own rights, duties,
immunities or obligations under this Agreement. 
 9.9. Severability. This Agreement shall be deemed severable, and the invalidity or
unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties
hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable; provided, however, that if any excluded
provision shall materially affect the rights, immunities, liabilities, duties or obligations of the Warrant Agent, the Warrant Agent shall be entitled to resign immediately upon written notice to the Company. 

9.10. Force Majeure. Notwithstanding anything to the contrary contained herein, the Warrant Agent shall not be liable for any delays or
failures in performance resulting from acts beyond its reasonable control including, without limitation, acts of God, terrorist acts, epidemics, pandemics, shortage of supply, breakdowns or malfunctions, interruptions or malfunctions of any
utilities, communications, or computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor difficulties, war or civil unrest. 

  
 22 

 9.11. Entire Agreement. This Agreement, together with the Warrant Certificate,
contains the entire agreement and understanding among the parties hereto with respect to the subject matter hereof, and supersedes all prior and contemporaneous agreements, understandings, inducements and conditions, express or implied, oral or
written, of any nature whatsoever with respect to the subject matter hereof. The express terms of this Agreement control and supersede any provision in the Warrant Certificate or the Subscription Agreement concerning the duties, obligations and
immunities of the Warrant Agent. 
 10. Certain Definitions. As used in this Agreement, the following terms shall have the respective
meanings set forth below: 
 “Business Day” shall mean a day, other than a Saturday, Sunday or federal holiday, on
which banks in New York City, New York and Brisbane, Australia are generally open for normal business. 
 “Convertible
Securities” means any securities (directly or indirectly) convertible into or exchangeable for Ordinary Shares, but excluding Options. 

“Excluded Issuances” means any issuance (or deemed issuance in accordance with Section 4.3) by the Company after
the Original Issue Date of: (a) Ordinary Shares issued upon the exercise of this Warrant; (b) up to $100 million in Ordinary Shares issued in a continuous offerings pursuant to an “at-the-market” program or committed equity facility; or (c) up to an aggregate of 10,000,000 Ordinary Shares (as such number of shares is equitably adjusted for subsequent stock splits, stock
combinations, stock dividends, and recapitalizations) issued directly or upon the exercise of Options to directors, officers, employees, or consultants of the Company in connection with their service as directors of the Company, their employment by
the Company, or their retention as consultants by the Company, in each case authorized by the Company’s Board of Directors and issued pursuant to the Tritium DCFC Limited Long-Term Incentive Plan, Shadow Equity Employee Scheme of Tritium
Technologies, LLC, Shadow Equity Employee Scheme of Tritium Technologies B.V. and Shadow Equity Employee Scheme of Tritium Pty Ltd. 

“Fair Market Value” as of a particular date means the closing price of the Ordinary Shares on the Nasdaq Stock Market
on such date. 
 “Financial Close” shall have the meaning given in the LNSA. 

“Initial Share Price” means the volume-weighted average price (VWAP) of the Ordinary Shares on the Nasdaq Stock Market
for the thirty (30) trading days preceding, but excluding, the date that the Utilisation Request (as defined in the LNSA) is submitted under the LNSA. 

“Options” means any warrants or other rights or options to subscribe for or purchase Ordinary Shares or Convertible
Securities. 
 “Person” means any individual, sole proprietorship, partnership, limited liability company,
corporation, joint venture, trust, incorporated organization or government or department or agency thereof. 

  
 23 

 “Relevant Interest” has the meaning it has in sections 608 and 609
of the Corporations Act 2001 (Cth). 
 Exhibit A — Form of Warrant Certificate 

  
 24 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of
the date first above written. 
  

			
	TRITIUM DCFC LIMITED, an Australian public company in accordance with section 127 of the Corporations Act 2001 (Cth)
		
	By:	 	/s/ Jane Hunter
		 	Name: Jane Hunter
		 	Title: Chief Executive Officer and Director
		
	By:	 	/s/ Michael R. Collins
		 	Name: Michael R. Collins
		 	Title: General Counsel and Company Secretary
	
	COMPUTERSHARE INC.
	 COMPUTERSHARE TRUST COMPANY, N.A.,

as Warrant Agent

		
	By:	 	/s/ Collin Ekegu
		 	Name: Collin Ekegu
		 	Title: Manager, Corporate Actions

 [Signature Page to Warrant Agreement] 

 EXHIBIT A 

[Form of Warrant Certificate] 

[FACE] 
 THE WARRANTS REPRESENTED BY THIS
CERTIFICATE AND THE SECURITIES ISSUABLE UPON EXERCISE OF THE WARRANTS HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER ANY STATE OR FOREIGN SECURITIES LAWS AND MAY NOT BE
OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (A) A REGISTRATION STATEMENT UNDER THE ACT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE ACT AND IS QUALIFIED UNDER APPLICABLE STATE AND FOREIGN LAW OR
(B) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE COMPANY REQUESTS, AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY,
TO SUCH EFFECT HAS BEEN RENDERED. 
 Number 

Warrants 
 TRITIUM DCFC
LIMTED 
 an Australian public company limited by shares 

Warrant Certificate 
 This
Warrant Certificate certifies that _____________________________, or its registered assigns, is the registered holder of warrant(s) evidenced hereby (the “Warrants” and each, a
“Warrant”) to subscribe for and purchase ordinary shares (“Ordinary Shares”) of Tritium DCFC Limited, an Australian public company limited by shares (the “Company”). Each
Warrant entitles the holder, upon exercise during the period set forth in the Warrant Agreement referred to on the reverse hereof, to receive from the Company that number of fully paid and validly issued Ordinary Shares as set forth below, at the
exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in lawful money of the United States of America (or through “cashless exercise” as provided for in the
Warrant Agreement) upon surrender of this Warrant Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms
used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement. 
 Each Warrant
shall entitle the holder to subscribe for and purchase one fully paid and validly issued Ordinary Share on the terms and conditions set forth in this Warrant Certificate and the Warrant Agreement. The number of Ordinary Shares issuable upon exercise
of the Warrants is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement. The initial Exercise Price per Ordinary Share for each Warrant is equal to $0.0001 per share. 

 Subject to the conditions set forth in the Warrant Agreement, the Warrants may be exercised
as follows: 
  

	 	(a)	 One third of the Warrants will vest and be immediately exercisable upon Financial Close (as defined in the
LNSA); 

  

	 	(b)	 One third of the Warrants will vest and be exercisable on the date that is nine (9) months after the date
of the Financial Close; and 

  

	 	(c)	 One third of the Warrants will vest and be exercisable on the date that is eighteen (18) months after the
date of the Financial Close. 

 Reference is hereby made to the further provisions of this Warrant Certificate set forth
on the reverse hereof and such further provisions shall for all purposes have the same effect as though fully set forth at this place. 

This Warrant Certificate shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement. 

This Warrant Certificate shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to
conflicts of laws principles thereof. 

  
 A-2 

 
			
	TRITIUM DCFC LIMITED
		
	By:	 	 
		 	Name:
		 	Title:
	
	COMPUTERSHARE INC.
	 COMPUTERSHARE TRUST COMPANY, N.A.,

as Warrant Agent

		
	By:	 	 
		 	Name:
		 	Title:

 [Signature Page to Warrant Certificate] 

  
 A-3 

 [Form of Warrant Certificate] 

[Reverse] 
 The Warrants evidenced
by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive Ordinary Shares and are issued or to be issued pursuant to the Warrant Agreement dated as of September 2, 2022 (the
“Warrant Agreement”), duly executed and delivered by the Company to Computershare Inc., a Delaware corporation, and its affiliate, Computershare Trust Company, N.A., a federally chartered trust company, as
warrant agent (the “Warrant Agent”), and the holders (the words “holders” or “holder” meaning the Registered Holders or Registered
Holder) of the Warrants, which Warrant Agreement is hereby incorporated by reference in and made a part of this instrument and is hereby referred to for a description of the rights, limitation of rights, obligations, duties and immunities thereunder
of the Warrant Agent, the Company and the holders. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant Certificate but not defined herein shall have the
meanings given to them in the Warrant Agreement. 
 The holder of Warrants evidenced by this Warrant Certificate may exercise vested
Warrants by surrendering this Warrant Certificate, with the form of written notice of the holder’s election to subscribe for and purchase Ordinary Shares as set forth hereon, properly completed and executed, together with payment of the
Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise
of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number
of Warrants not exercised. 
 The Warrant Agreement provides that upon the occurrence of certain events the number of Ordinary Shares
issuable upon exercise of the Warrants set forth on the face hereof may, subject to certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest in an Ordinary Share, the
Company shall, at its election, either (i) pay to the holder of the Warrant an amount in cash (by wire transfer of immediately available funds) equal to the product of (x) such fraction, multiplied by (y) the Fair Market Value of one
Ordinary Share on the Exercise Date or (ii) round up to the nearest whole number the number of Ordinary Shares to be issued to such holder of the Warrant. 

Warrant Certificates, when surrendered at the principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person
or by legal representative or attorney duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or
Warrant Certificates of like tenor evidencing in the aggregate a like number of Warrants. 

  
 A-4 

 Upon due presentation for registration of transfer of this Warrant Certificate at the office
of the Warrant Agent a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the limitations
provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection therewith. 
 The
Company and the Warrant Agent may deem and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise
hereof, of any distribution to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the Warrants nor this Warrant Certificate entitles any holder
hereof to any rights of a stockholder of the Company. 

  
 A-5 

 Notice of Election to Subscribe and Purchase 

(To Be Executed Upon Exercise of Warrant) 

The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to subscribe for and receive
________________Ordinary Shares and herewith tenders payment for such Ordinary Shares to the order of Tritium DCFC Limited (the “Company”) in the amount of $___________ in accordance with the terms hereof. The undersigned
requests that a certificate for such Ordinary Shares be registered in the name of _______________________________, whose address is ________________________________ and that such Ordinary Shares be delivered to whose address is
__________________________. If said number of Ordinary Shares are less than all of the Ordinary Shares which may be subscribed for and purchased hereunder, the undersigned requests that a new Warrant Certificate representing the remaining balance of
such Ordinary Shares be registered in the name of __________________________, whose address is __________________________________ and that such Warrant Certificate be delivered to ________________________________, whose address is
________________________________. 
 In the event that the Warrant is exercised in accordance with the Warrant Agreement through
“cashless” exercise (i) the number of Ordinary Shares that this Warrant is exercisable for will be determined in accordance with Section 3.3.1 of the Warrant Agreement; and (ii) the holder hereof shall complete the
following: 
 The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, through the cashless exercise
provisions of the Warrant Agreement, to receive Ordinary Shares. If said number of shares is less than all of the Ordinary Shares which may be subscribed for and purchased hereunder (after giving effect to the cashless exercise), the undersigned
requests that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered in the name of __________________________, whose address is __________________________ and that such Warrant Certificate be delivered to
__________________________, whose address is __________________________. 
 [Signature Page Follows] 

  
 A-6 

					
	 Date:         , 20__
	 	

 
	
	 
	(Signature)
	
	 
	(Name)
	
	 
	
	 
	
	 
	
	 
	(Address)
	
	 
	(Tax Identification Number)

  
 A-7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]